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In this study, it is decided to throw light on some intravenous anaesthetic 
protocols to be used in female desert goats in Sudan. The main objective of this 
study is to provide baseline data pertaining to different anaesthetic phases tested 
and to compare and contrast the different examined protocols.  
This study was conducted using 64 healthy female desert goats divided 
randomly into eight groups of equal size. Ketamine Hcl (KT) (5%) at dose rate of 
4mg/kg body weight and Thiopentone Sodium (TH) (2.5%) at dose rate of 10mg/kg 
body weight were used as induction agents injected intravenously in all examined 
protocols. Diazepam (DI) (0.5%) at dose rate of 0.5mg/kg body weight, Xylazine 
(XY) (2%) at dose rate of 0.1mg/kg body weight and Medetomidine (ME) at dose 
rate of 10µg/kg body weight were used as premedications, individually injected 
intravenously 10 minutes prior to Ketamine Hcl or Thiopentone Sodium (TH) 
injection. Each of the above mentioned groups of animals were subjected to 
treatment either with KT or TH with or without one of the above mentioned 
premedications, so the tested protocols were KT, KT-DI, KT-XY, KT-ME, TH, 
TH-DI, TH-XY and TH-ME.    
Respiratory rate, heart rate and rectal temperature were measured before and 
immediately after injection of premedications and anaesthetics at 10 minutes 
intervals until full recovery was attained as monitor, using standard clinical 
methods. The major reflexes were monitored throughout the course of anaesthesia. 
The usage of the protocols KT, KT-XY and KT-ME induced significant 
increase in respiratory rate, while TH-DI and TH-XY exerted significant decrease 
in respiration. There was significant tachycardia due to injection of TH, TH-DI and 
TH-XY, and significant bradycardia due to injection of TH-ME. The usage of TH 
and TH-DI induced significant hyperthermia, while none of the protocols tested 
harboured significant hypothermia.  
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Thiopentone sodium containing protocols (TH-DI, TH-XY, and TH-ME) 
were found to have longer duration of anaesthetic phase, when compared with that 
observed with Ketamine or Thiopentone sodium when used without premedication. 
The longest duration of basal narcosis was induced with the protocol TH-ME, 
while KT harboured the shortest one. The protocol KT-ME induced the longest 
mean period of lateral recumbancy phase and KT-DI exerted the shortest one. The 
longest mean value of the sternal recumbancy phase in different protocols tested 
was induced with TH-DI, while the KT-XY harboured the shortest one. The longest 
mean value of standing phase was noticed with TH-DI, and the shortest one with 
ME-KT. There was no obvious relationship between phases of anaesthesia and 
regained time of selected reflexes tested.  
There is significant increase in total recovery time (TRT) when 
premedications were used prior to Ketamine or Thiopentone sodium. Also 
generally, Thiopentone sodium containing protocols were reported to have 
significantly longer duration of TRT than Ketamine Hcl containing protocols.  
Apnoea was observed when Thiopentone sodium containing protocols were 
used. The longest duration of apnoea was induced with TH-DI, the shortest one was 
due to injection of TH-XY. 
This study concludes that each of the eight tested protocols at the prescribed 
dose rates is safe for use in female desert goats, with variable effects on 
physiological and anaesthetic parameters. 
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Goats seem to have been first domesticated roughly 10,000 years ago in the 
Zagros Mountains of Iran. The domestic goat (Capra aegagrus hircus) is a 
domesticated subspecies of the wild goat of southwest Asia and Eastern Europe. It is a 
member of the bovine family and is closely related to the sheep, both being in the 
goat antelope group. They have been used for their milk, meat, hair, and skins all over 
the world. In the last century they have also gained some popularity as pets. 
Historically, goat hide has been used for water and wine bottles in both traveling 
and transporting wine for sale. It has also been used to produce parchment, which 
was the most common material used for writing in Europe until the invention of the 
printing press. Goats are gaining acceptance as an established model for biomedical 
research and for surgical training and teaching. They are used in medical, 
orthopedic, psychological, chemotherapeutic, and physiologic research (Lincicome 
and Hall, 1984). 
General anaesthesia either it is intravenous or inhalation anaesthesia is 
increasingly being used for surgical interferences in goats, such as caesarean 
section embryotransfere, laparotomy, and the various amputations.  
Anaesthesia is required whenever an animal is subjected to surgery. It’s vital 
from humanitarian point of view, but it is also required by law that effective 
measures are adopted to prevent suffering during painful procedures. There are also 
times when anaesthesia was used as a means of restraint (even if no pain is 
involved) such as for radiography, when manual restraint is not allowed for reasons 
of personal safety. 
General anaesthesia implies the loss of consciousness so that awareness is 
lost and events can not be recalled. Drugs which induce general anaesthesia may be 
administered intravenously, intramuscularly, or by inhalation. Choice of the 
technique is influenced by facilities available, skill and experience of the 
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anesthetist, the temperament of the animal, the species, breed, age, health of the 
animal, nature and duration of the surgical operation.   
The disadvantages to inhalant anaesthesia are the complexity and cost of the 
equipment needed to administer the anesthesia, and potential hazards to personnel. 
All inhalant drugs are volatile liquids; they should not be stored in animal rooms 
because the vapors are either flammable or toxic to inhale over extended periods of 
time. In particular, ether must be stored in a proper hood or cabinet designed for 
flammable materials. Intravenous anaesthesia (IVA) is now well established in 
most areas of anaesthetic provision and is the preferred technique in the eyes of 
some practitioners. 
In Sudan and many other third world countries, Veterinary anaesthesia and 
inhalation anesthesia in particular is still lagging behind because of unavailability 
of anaesthetic drugs, the lack of continuous financial support for anaesthetic 
practice and training and the lack of sophisticated equipment such as anaesthetic 
machines and their accessories as well as the lack of servicing facilities to these 
equipment. 
Taking into consideration the above mentioned problems facing inhalation 
anaesthesia in Sudan and many other third world countries, total intravenous 
anaesthesia will still have a vital role to play particularly under field conditions 
where no inhalation anaesthetic facilities are available.  
In Sudan, Ghurashi, (1999) conducted experiments in healthy desert goat 
kids using Thiopentone sodium (2.5%) at three different dose levels viz: 10, 15 and 
20 mg/kg, he suggested that increasing Thiopentone sodium dose resulted in an 
increase in the duration of the different anaesthetic phases. Respiration and heart 
rate were affected significantly (p<0.05) as a result of using Thiopentone sodium at 
  
20
the three different levels, while rectal temperature was affected non-significantly in 
the three groups.  
Nuha (2004), conducted other experiments in Nubian goat kids using 
combined protocols of Thiopentone or Ketamine with premedications (Xylazine or 
Medetomidine), antidote Atipamizole and local analgesic Lidocaine, her results 
showed that there was non significant changes in respiratory rate following 
induction of anaesthesia with 4 protocols out of 6 protocols tested. Apnoea 
occurred only in association with protocol Thiopentone sodium-Xylazine. 
Significant bradycardia occurred in association with all protocols tested except the 
protocol Thiopentone sodium-Xylazine. Rectal temperature was significantly 
dropped when Thiopentone sodium was used as an induction agent in Xylazine 
premedicated animals, and when Medetomidine was used in combination with 
Ketamine.      
Batoul, (1990), studied general anaesthesia in goats with Thiopentone 
sodium (5%) at dose rate 20 mg/kg body weight. and its effects on some 
haematological parameters.  
Objectives of this study: 
1. To evaluate selected intravenous anaesthetic protocols for use in desert 
female goats. 
2. To study the effects, if any, of the selected anaesthetic protocols on some 
physiological parameters of desert goats. 
3.  To compare and contrast the results obtained using the different selected 
anaesthetic protocols. 
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CHAPTER ONE 
Literature review 
1. Intravenous anaesthesia in goats 
Anaesthesia is an indispensable pre-requisite to most of the surgical 
interventions, both in humans and animals, so that the surgeon can perform surgical 
intervention with maximum precision and sagacity. Anaesthetics are available for 
both parenteral as well as inhalation routes. In the developing countries total 
intravenous anaesthesia still represents a good choice for surgical interference and 
this may be due to complexity and cost of the equipment needed to administer the 
inhalation anesthesia. As well as in Sudan, due to meager facilities available for 
field veterinarians. In Pakistan intravenous anaesthetics are preferred, because of 
their early and safe induction (Muhammad, Zafar, Muhammad, Masood, Manzoor, 
and Sarfaraz, 2009). 
Injectable anaesthetics are distinguished from inhalation anaesthetics (gases 
or volatile liquids) in being solid compounds which may be dissolved in water, 
solubilized by incorporating water- based preparations suitable for intravenous, 
intramuscular and occasionally intraperitoneal injection or other parenteral route 
(Brander, Pugh, Bywater, and Jenkins, 1991). The ideal intravenous anaesthetic 
agents should be water soluble, stable (in solutions or when exposed to light over a 
long time), have no damage to venous or body tissues, has short action and it's 
inactivation is carried out through metabolism, have nontoxic metabolites, no 
histamine release and minimal harmful cardiorespiratory effects (Dundee, 1978). 
Each of Injectable anaesthetics has side effects and none of them was regarded as 
ideal (Brander et al., 1991).   
Sedation and general anaesthesia in sheep and goats is usually uncomplicated 
except notable regurgitation with potentially fatal pulmonary aspiration (Hall, 
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Clarke and Trim, 2001). In addition, Ghurashi, (1999) reported that, salivation, 
tympany and regurgitation of rumen contents are the chief difficulties during 
general anaesthesia in ruminants.  
1.1. Thiopentone sodium (thiopental) 
Thiopentone sodium was introduced into Veterinary practice in UK in 1973 
(Hall et al., 2001). It's known as an ultra short-acting barbiturate (Susan and 
Donald, 2003; Hall et al., 2001). 
1.1.1 Identity 
Thiopentone sodium is a mixture of mono sodium salts usually available as 
powder to be dissolved in water before use (Hall et al., 2001). It is a white to 
yellowish, crystalline powder, odorless, soluble in water, alcohol and highly 
soluble in lipids. Commercially available drug for injection contains anhydrous 
sodium carbonate as a buffer. The powder stored at a controlled room temperature 
of 15–30°C (AHFS, 2005). Because of its irritant effect, Thiopentone sodium must 
be injected intravenously (Hall et al., 2001). 
1.1.2. Chemical name  
It is a 5- ethyl -5- (1-methyl butyl) -2- thiobarbiturate (100 parts w/w) and 
exsiccated sodium carbonate (6 parts w/w) (Vickers, Shnienden, and Wood-Smith, 
1984)  
1.1.3. Molecular formula 
Its molecular formula is C12H19N2 Na O2S 
1.1.4. Mode of action 
  Thiopentone sodium binds at a distinct binding site associated with a Cl- 
ionopore at the gamma amino butric acid (GABA) receptor increasing the duration 
of time for which the Cl- ionopore is open (Olsen, 1981). The post-synaptic 
inhibitory effect of GABA in the thalamus is, therefore, prolonged. 
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Figure 1.1 Chemical structure of Thiopentone sodium 
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1.1.5 Pharmacology 
Induction doses of this drug are usually between 5 and 10 mg/kg for use in 
most species (Hall et al., 2001), and 1.25%, 2.5%, 5% solutions are used in most 
animals depending on animal's size (Thurmon, Tranquilli, Benson, and Lumb, 
1996).   
The duration and depth of anaesthesia due to injection of Thiopentone 
sodium depend on the amount of the injected drug, speed of injection, rate of 
distribution of the drug in the non-fatty tissues of the body, rate of uptake of the 
drug by the body fat, and using of premedication (Batoul, 1990; Rawling and 
Kolata, 1983; Hall et al., 2001). Thiopentone sodium appears to cross the blood-
brain barrier with very great speed and after intravenous injection it rapidly reaches 
the central nervous system and its effects become apparent within 15 - 30 seconds 
(Hall et al., 2001). Susan and Donald, (2003) reported that Thiopentone sodium is 
highly soluble in lipid, and rapidly enters the CNS producing profound hypnosis 
and anesthesia, and then redistributes to muscle and adipose tissue in the body. The 
short duration of action of this agent is due to redistribution out of the CNS and 
into muscle and fat stores less than to rapid metabolism, so Greyhounds and other 
sight hounds may exhibit longer recovery times than other breeds. This may be due 
to their low body fat levels or differences in the metabolic handling of the 
thiobarbiturates (Susan and Donald, 2003). After a single dose, concentration of 
Thiopentone sodium rises highly in plasma and liver immediately after injection 
and soon fell rapidly. Also muscle concentration rises high immediately after 
injection, but continued to rise for some 20 minutes, then fells rapidly during the 
first hour then becomes progressively slower in the next two to three hours. 
Concentration of this agent in the body fat neglected immediately after injection, 
then increased rapidly during the first hour, and then more slowly until reached its 
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maximum in three to six hour after single dose injection (Hall et al., 2001). Rapid 
intravenous injection of an initial dose of Thiopentone sodium in a dose rate of 15 – 
20 mg/kg in a concentration of 5%, produces anaesthesia and 30 – 50 seconds of 
apnoea in goats (Hall and Clarke, 1983). Several metabolites have been isolated 
after metabolism of Thiopentone sodium through the hepatic microsomal system 
and very little of the drug is excreted unchanged in the urine (Susan and Donald, 
2003; Thurmon et al., 1996). Recovery from Thiopentone sodium anaesthesia is 
reported to be quick and quiet (Hall and Clarke, 1991).  
1.1.6. Toxic effects   
Depression of the respiratory center was reported to be as the main toxic 
effect of Thiopentone sodium (Hall et al., 2001).  Significant vascular dilatation 
and hypoglycemia were observed when Thiopentone sodium is injected too rapid 
intravenously (Susan and Donald, 2003). Cats are susceptible to developing apnoea 
after injection and may also develop a mild arterial hypotension (Susan and 
Donald, 2003). In goats, injection of Thiopentone sodium causes tachycardia at 
different times (Contreras and Aspe, 1992). 
Batoul, (1990), studied general anaesthesia in goats with Thiopentone 
sodium (5%) at dose rate of 20 mg/kg body weight and its effects on some 
haematological parameters. She reported that general anaesthesia when applied 
once caused a decrease in the number of red blood cells (RBCs) and increase in 
mean cell volume (MCV), when compared with pre-trial values. Repeated general 
anaesthesia for three successive days, affect the values of Haemoglobin (Hb), 
Packed Cell Volume (PCV) and (MCV) with significant decrease in values. Total 
number of White Blood Cells (WBCs) was not affected. The number of 
Neutrophils was significantly decreased and monocytes were increased.  
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1.1.7. Use of Thiopentone sodium in goats 
Anaesthetic induction dose of Thiopentone sodium is 7- 20 mg/kg in the 
unpremedicated animal, but recommended initial dose is 5 – 7 mg/kg of 2.5% 
solution to avoid overdose in goats (Hall et al., 2001). 
Ghurashi, Sobair, Seri, and Ashwag, (2007) studied some physiological and 
anaesthetic effects of this drug at dose rate of 10 mg/kg administered intravenously  
in goat kids premedicated with acepromazine or diazepam or Xylazine and non 
premedicated animals. They suggest that the use of premedication prior to 
thiopentone sodium lead to smooth induction of anaesthesia rather than non 
premedicated animals. They also reported that physiological parameters 
(respiratory rate, heart rate and rectal temperature) were affected to different limits, 
and the usage of premedications especially xylazine lead to improvement of 
Thiopentone sodium anaesthetic effects.    
1.2 Ketamine Hcl (Ketalar) 
Ketamine hydrochloride is a dissociative anaesthetic and a member of the 
phencyclidine group. It is a short acting anesthetic agent being widely used in 
recent years. It is developed in 1963 to replace phencyclidine and is being currently 
used for human and veterinary anesthesia (Tanaka, Honda, Yasuhara, 2005). 
Ketamine is a cardiovascular stimulant and it has been used for spinal analgesia in 
humans (Bion, 1984) and animals (Aithal, Amarpal, and Singh, 1996; Gomez de 
Segura, 1998; DeRossi, Junqueira, Lopes, and Beretta, 2005). Ketamine is used for 
premedication, sedation, induction and maintenance of general anaesthesia (Sinner 
and Graf, 2004; Huai-Chia, Ta-Liang, and Ruei-Ming, 2009; Rose, Matthias, 
Saskia, Michael, Andreas, Gunter, Horst, and Andrea, 2005).  
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1.2.1 Identity 
The drug is a water and lipid soluble, allowing it to be administered 
conveniently via various routes and providing extensive distribution in the body 
(Sinner and Graf, 2004). The drug is manufactured as injectable odorless and 
tasteless liquid (Tanaka, et. al., 2005). 
1.2.2 Chemical name 
  It is a 2-(o-chlorophenyl)-2- methylamino)- cyclohexanone.  
1.2.3 Molecular formula  
Its molecular formula is C13 H18 N O Cl  
1.2.4 Mode of action 
Ketamine was originally presented as a racemic mixture of two isomers (S+ 
and R–). The (S+) isomer is 3–4 times as potent as an analgesic with a faster 
clearance than (R–) (Sneyd, 2004; Sinner and Graf, 2004; Rose et al., 2005). This 
drug acts on a variety of receptors, including nicotinic (Scheller et al., 1996), 
muscarinic (Hustveit et al., 1995; Sinner and Graf, 2004), and opioid receptors 
(Finck and Ngai, 1982; Smith et al., 1987; Hustveit et al., 1995; Sinner and Graf, 
2004) and affects the N-methyl-d-aspartate (NMDA) receptor complex channel as a 
noncompetitive antagonist at the phencyclidine receptor site (Yamamura et al., 
1990; Sinner and Graf, 2004). Rose and his team (2005) concluded that Ketamine 
blocks Na+ and K+ channels in superficial dorsal horn neurons of the lumbar spinal 
cord there by reducing the excitability of the neurons, which may play an important 
role in the complex mechanism of its action during spinal anaesthesia. 
1.2.5 Pharmacology 
Ketamine can be administrated via intramuscular or intravenous route (Hall 
et al., 2001), epidurally in goats (Aithal et al., 1996). Thurmon et al., (1996) 
reported that unconsciousness and analgesia due to injection of Ketamine are dose  
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Figure 1.2 Chemical structure of Ketamine 
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related. This drug produces analgesia (without muscle relaxation) and increase 
salivation (Hall et al., 2001). Sinner and Graf, (2004) stated that Ketamine causes 
bronchodilation, stimulation of the sympathetic nervous system and cardiovascular 
system. Ketamine crosses the brain blood barrier rapidly and because of its brain / 
plasma ratio becomes constant in less than one minute, the onset of action is rapid 
(Hall et al., 2001). Ketamine metabolism is mediated by hepatic microsomal 
enzymes, and excreted as four metabolites in the urine (Hall et al., 2001; Sinner 
and Graf, 2004).  
1.2.6 Toxic effects  
Impaired motor function, high blood pressure, depression and potentially 
fatal respiratory suppression were reported to be the most toxic effects of Ketamine 
Hcl (Tanaka et al., 2005).  
1.2.7 Use of Ketamine Hcl in goats 
Without fear of causing convulsion, Ketamine Hcl can be used in sheep and 
goats, and muscle relaxation due to its administration is poor (Hall et al., 2001). 
Ketamine has been acclaimed on account of its safety and its favourable effects 
upon cardiovascular and respiratory systems and because of its sympathomimetic 
and antiarrhythmic properties, it is useful in poor-risk and hypovolaemic patients 
(Idvall, Ahlgren, Stenberg, 1979). Ketamine produce stage of sedation with 
profound analgesia and partial depression of cough and swallowing reflexes (Hall 
et al., 2001). 
1.3 Diazepam 
Diazepam is probably the most widely used of the benzodiazepines (Hall et 
al., 2001). It is one of the most widely prescribed drugs in the world. Clinically 
Diazepam is administers prior to general anaesthetics as psychoseditive 
premedication for endoscopic and bronchoscopic procedures, as anticonvulsant to 
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control intractable seizure activity and as an anxiolytic to moderate anxiety and 
agitation (Sellers, 1978). Premedication with diazepam increase the length of action 
of other anaesthetic agents and the drug is particularly useful prior to Ketamine 
anaesthesia to reduce the hallucinations which seem to be associated with Ketamine 
anaesthesia (Hall et al., 2001). Marrs (2004) reported that, diazepam is indicated in 
convulsions or pronounced muscle fasciculation caused by organophosphorus 
insecticides poisoning. 
1.3.1 Identity  
Diazepam is a white to yellow, tasteless initially, but a bitter after-taste 
develops, odourless crystalline powder with a melting point between 131-135°C 
(Susan and Donald. 2003; Marrs, 2004). The drug is insoluble in water and 
solutions for injections contain solvents such as propylene glycol, ethanol and 
sodium benzoic acid (Hall et al., 2001). One gram is soluble in 333 ml of water, 25 
ml of alcohol, and it is sparingly soluble in propylene glycol. The pH of the 
commercially prepared injectable solution is adjusted with benzoic acid/sodium 
benzoate to 6.2-6.9. It consists of a 5 mg/ml solution with 40% propylene glycol, 
10% ethanol, 5% sodium benzoate/benzoic acid buffer, and 1.5% benzyl alcohol as 
a preservative (Susan and Donald. 2003; Marrs, 2004). Diazepam should not be 
mixed with other drugs in the same infusion solution or in the same syringe as there 
are numerous incompatibilities (Trissel, 2003). 
1.3.2 Chemical name 
It is a 7-chloro-1, 3-dihydro-1-methyl-5-phenyl-2H-1, 4-benzodiazepin-2-
one (Marrs, 2004). 
1.3.3 Molecular formula 
Diazepam molecular formula is C16H13ClN2O  
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Figure 1.3 Chemical structure of diazepam  
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1.3.4 Mode of action 
The action of benzodiazepine compounds is thought to be through 
stimulation of specific benzodiazepine (BZ) receptors (Hall et al., 2001). Their 
main sedative effects are through depression of the limbic system, and their muscle 
relaxing properties are through inhibition of the internuncial neurones at spinal 
levels (Hall et al., 2001). Susan and Donald (2003) reported that the exact 
mechanism of action is unknown, but postulated mechanisms include: antagonism 
of serotonin, increased release of and/or facilitation of gamma-aminobutyric acid 
(GABA) activity, and diminished release or turnover of acetylcholine in the CNS.  
1.3.5 Pharmacology 
Diazepam can be administered intravenously, intramuscularly, orally and 
rectally via suppository or enema (Barbara Forney, 2002). The sub cortical levels 
(primarily limbic, thalamic, and hypothalamic) of the CNS are depressed by 
diazepam producing the anxiolytic, sedative, skeletal muscle relaxation, and 
anticonvulsant effects (Susan and Donald, 2003). After oral administration  
Diazepam is rapidly absorbed and reached peak plasma levels within 30 minutes to 
2 hours. However it was slower than oral and incompletely absorbed following 
intramuscular administration (Susan and Donald, 2003). Diazepam is metabolized 
by the liver to nordiazepam and other active metabolites which are excreted in the 
urine (Barbara Forney, 2002). 
1.3.6 Toxic effects 
Intravenous injection of diazepam may cause thrombophlebitis and this is 
thought to be due to the solvent rather than to diazepam itself (Hall et al., 2001). 
1.3.7 Use of Diazepam in goats  
Diazepam when injected intravenously and alone in sheep and goats may 
produce some sedation and ataxia for 15 – 30 minutes, but the degree of sedation is 
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unpredictable in healthy animal (Hall et al., 2001). At dose rate of 0.2 mg/kg 
intravenously injected Diazepam can be used to produce mild sedation for 
transdermal tracheal wash (Hall et al., 2001). 
1.4 Xylazine  
Xylazine is the most widely used agent for chemical restraint in ruminants 
including goats. It has sedative, analgesic and muscle relaxing properties. It has a 
wide acceptance because of good tolerance and the optional intramuscular and 
intravenous administration (Ndeereh, Mbithi, and Kihurani, 2001). Xylazine is a 
powerful tranquilliser, which is commonly used to sedate large animals especially 
prior to surgical procedures. Anaesthetic effects and muscle relaxing properties 
may vary in intensity depending on the administrating dose (Spyridaki, Lyris, 
Georgoulakis, Kouretas, Konstantinidou, and Georgakopoulos, 2004). It is 
commonly used alone or in combination with other sedatives, analgesic or 
anaesthetic agents.  Though Xylazine is relatively safe to use in ruminants, 
prolonged recovery is not uncommon, especially when high dose rates were used 
(Knight, 1980).  
1.4.1 Identity 
Xylazine is an organic base which is administered as an aqueous solution of 
hydrochloride salt (Brander et al., 1991).   
1.4.2 Chemical name  
It is a 2(2, 6-dimethyl phenylamino) - 4H - 5, 6 – dihydro - 1, 3 – thiazine - 
hydrochloride) (Thurmon et al., 1996).  
1.4.3 Molecular formula  
Xylazine molecular formula is C12H16N2S  
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Figure 1.4 Chemical structure of Xylazine 
  
36
1.4.4 Mode of action 
Xylazine stimulates directly peripheral α2-adrenergic receptors located in 
various tissues (Kobinger, 1978).  Prolonged analgesia, with a long duration of 
action observed when Xylazine injected into the subarachnoid space, is mediated 
by the α2-adrenergic receptors located in the dorsal horn of the spinal cord. Muscle 
relaxation due to Xylazine was reported to be through inhibition of intraneural 
transmission of impulses in the central nervous system (Thurmon et al., 1996). 
1.4.5 Pharmacology 
This drug can be used in all domestic animals with various doses (Brander et 
al., 1991). It can be administrated by intravenous, intramuscular, or subcutaneous 
routes (Hall et al., 2001), and spinally in goats (Kinjavdekar, Singh, Amarpal, 
Aithal, and Pawde, 2007). Intramuscular injection of Xylazine at 0.44 mg/kg 
produced continued recumbency, analgesia and marked sedation at approximately 
10 minutes (Ndeereh et al., 2001).  Reduction of the recovery period in sedated 
ruminants would minimize risks of such complications, ruminants (especially 
goats) require small doses of Xylazine with an agent to reverse the effects of 
Xylazine would be useful for treating accidental overdose (Ndeereh et al., 2001). 
Analgesic and sedative effects of Xylazine can be reversed with α2 adrenoceptors 
antagonists (Brander et al., 1991).  There are marked variations in susceptibility to  
Xylazine between the various species of domestic animals. Horses, dogs and cats 
require 10 times the dose needed in cattle. Pigs are even more resistant than horses 
(Hall et al., 2001). It is possible that lesser variations in sensitivity may occur in 
breeds within a single species and this might contribute to the occasional failure of 
the drug to produce sedation (Hall et al., 2001). Xylazine is metabolized in the liver 
and excreted via kidneys (Hall and Clarke, 1983). 
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Xylazine causes sedation primarily by stimulating the central nervous system 
presynaptic α2-adrenergic receptors. It produces a profound hypertensive response 
within 15 seconds after injection. It also depresses cardiac minute work, 
mechanical index of myocardial oxygen demand and coronary blood flow in a 
similar manner (Spyridaki et. al., 2004). 
Xylazine is absorbed, metabolised and eliminated extremely rapidly. It is 
metabolised to many different compounds, the final breakdown products being 
organic sulphates and carbon dioxide. The pharmacokinetic disposition of xylazine 
hydrochloride has been described after both intravenous and intramuscular 
injection in horse, cattle, sheep and dog. In the horse, following an intravenous 
administration, the maximum sedative effect occurs within 4–8 minutes after 
injection. Following an intramuscular administration, sedation is usually evident 
within 10 minutes and reaches its maximum effect by 15 minute. Thus, in horses, 
clinical and pharmacokinetic data suggest that Xylazine itself, and not a metabolite, 
is the active drug (Garcia-Villar, Toutain, Alvinerie, and Ruckebusch, 1981; 
Spyridaki et. al., 2004). The main pathway of biotransformation is most likely via 
1-amino-2,6- dimethylbenzene, which is formed when the thiazine ring breaks 
down (Spyridaki et. al., 2004). 
1.4.6 Toxic effects   
Xylazine causes marked hypertension and bradycardia in dogs and cats, 
sweating in horses and in late pregnancy lead to premature delivery in cattle 
(Brander et al., 1991). At the time of maximum sedation, the aspiration pneumonia 
and pressure damage to nerves and muscles may arise due to prolonged recovery 
periods of Xylazine. Also pronounced salivation and/or excessive depression of the 
central nervous, cardiovascular, respiratory and gastrointestinal systems were 
reported as Xylazine complications (Taylor, 1990).   
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1.4.7 Use of Xylazine in goats 
Dose rate for Xylazine in goats range from 0.02 to 0.2 mg/kg in which 
Xylazine provides light to heavy sedation according to the dose rate administered. 
Use of this agent alone provide satisfactory sedation for restraint or can be used for 
premedication prior to induction of anaesthesia with other agents (Hall et al., 
2001). 
Intravenous injection of xylazine Hcl at dose rate of 0.05 mg/kg   in Nubian 
goat kids caused the animals to assume recumbancy position (Nuha, 2004). 
1.5 Medetomidine (Domitor) 
Medetomidine is a α2-adrenergic receptor agonist. It has analgesic, sedative, 
and muscle relaxation properties (Mpanduji, 2001). It is highly selective, specific 
and potent α2-adrenoreceptor agonist and induces more potent pharmacological 
effects as compared to Xylazine (Pawde, Amarpal, Singh, and Naveen, 1996).  
Premedication with medetomidine decreased anaesthetic requirements during 
anaesthesia with thiopentone sodium, halothane and nitrous oxide (Bergstrom, 
1988; Young and Jones, 1990), propofol and halothane (Bufalari, Short, Giannoni, 
Pedrick, Hardie, and Flanders,1997), isoflurane (Kuusela, Raekallio, Väisänen, 
Mykkanen, Ropponen, and Vainio, 2001; Ewing, Mohammed, Scarlet, and Short , 
1993) propofol (Vainio, 1991; Cullen and Reynoldson, 1993; Hammond and 
England, 1994; Bufalari, Short, Giannoni, and Vainio, 1996), halothane (Vickers, 
Sheridan, Segal, and Maze, 1988; Segal et al., 1989) in dogs. A recent study 
suggests that, as a premedicant to general anaesthesia, medetomidine may possess 
comparatively better potential to attenuate perioperative stress responses in dogs 
than sedatives such as acepromazine (Vaisanen et al., 2002). Medetomidine has 
also been used as a premedicant before general anaesthesia in rabbits, sheep and 
horses (Flecknell and Liles, 1996; Kastner, Boller, Kutter, Akens, and Bettschart, 
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2001; Yamashita, Muir, Tsubakishita, Abrahamsen, Lerch, Hubbell, Bednarski, 
Skarda, Izumisawa, and Kotani, 2002). In horses premedicated with medetomidine, 
transition to inhalational anesthesia was smoother than those premedicated with 
Xylazine (Yamashita et al., 2002). 
The drug has been widely used in combination with other drugs to prolong 
recumbency and the most popular combination is with Ketamine Hcl (Hall et al., 
2001). Medetomidine /Ketamine combination have been found to provide excellent 
immobilization and relaxation in wide range of species of animals, while the ability 
to reverse the sedation with α2-adrenoceptor antagonists has proved to be 
particularly useful (Jalanka, 1989).  
1.5.1 Identity 
It is a white or almost white crystalline substance, soluble in water (Susan 
and Donald, 2003). This drug is a racemic mixture of equal proportions of two 
optical enantiomers – the levo- and dextro-rotatory optical isomers (MacDonald et 
al., 1991) 
1.5.2 Chemical name  
Medetomidine is a 4-[1-(2, 3-dimethyl phenyl) - ethyl] 1H-imidazole (Hall et 
al., 2001; Mpanduji, 2001; Pawde et al., 1996).  
1.5.3 Molecular formula   
Medetomidine molecular formula is C13H16N2.HCl 
1.5.4 Mode of action 
The mode of action of Medetomidine is mainly through activation of α2 
adrenoceptors (very potent, selective and specific) full agonist at pres-synaptic and 
post-synaptic α2 adrenoceptors (Hall and Clarke, 1991).  
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Figure 1.5 Chemical structure of Medetomidine 
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1.5.5 Pharmacology 
Medetomidine produces sedation, muscle relaxation and analgesia in dogs 
(Vainio et al., 1989; Serteyn et al., 1993), cats ( Pawde et al., 1996), human beings 
(Scheinin M. 1987), wild animals (Jalanka, 1990), laboratory animals (Nevalainen 
et al., 1989) and Shami goat kids (Mohammed et al., 1991). The solution of 
Medetomidine is not irritant and can be administrated by subcutaneous, 
intramuscular, intravenously or sublingually (Hall et al., 2001).  
Susan and Donald, (2003), reported that Medetomidine has rapid onset of 
effect (5 minutes for IV; 10-15 minutes for IM). Also they showed that the drug 
can be absorbed via the oral mucosa when administered sublingually in dogs, but 
efficacy at a given dose may be less than intramuscular dosing. 
Pharmacological activity of medetomidine is stereospecific and is due 
predominantly to its dextro-rotatory isomer (Segal et al., 1988; Virtanen et al., 
1988).  
Following subcutaneous (rat) and intramuscular (dog) administration, 
medetomidine is rapidly absorbed into the blood stream and rapidly distributed into 
well-perfused tissues, including the brain, effectively penetrating these tissues and  
readily reaching its target receptors (Salonen, 1989). Sedation and analgesia 
induced by medetomidine in animals are dose-dependent and reach ceiling points 
beyond which increasing the dose may only prolong the duration of these responses 
but not their intensities (Vainio et al., 1989). 
Elimination occurs mainly by biotransformation in the liver, the rate of 
which may be controlled by hepatic blood flow (Salonen, 1989). Medetomidine is 
rapidly excreted mostly via the urine as metabolites with no pharmacological 
activity, and only traces of the drug are excreted unchanged (Salonen, 1989). 
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Following an intramuscular administration of 80 µg/kg medetomidine in 
cats, absorption occurred rapidly. Peak serum concentration (24.6 ng/ml) was 
reached within 15 minutes of drug administration and absorption half-life was 8 
minutes (Salonen, 1989). Distribution occurred rapidly and tissue penetration was 
effective (Salonen, 1989). The apparent volume of distribution was found to be 3.5 
l/kg and most of the drug existed in circulation in its inactive protein-bound form, 
with only 15% remaining as a free fraction (Salonen, 1989). Half-life of 
elimination was 1.35 hrs and total clearance was 29.5 ml/min kg (Salonen, 1989). 
About two-thirds of the original dose of drug was excreted via urine, mostly as 
pharmacologically inactive metabolites during the first 24 hrs after dosing, with 
very little found in faeces (Salonen, 1989). Unlike in other animals, cat urine 
contained no or negligible amounts of β-glucuronidase hydrolysable conjugates 
(Salonen, 1989). 
1.5.6 Toxic effects   
The drug decreases body temperature, heart rate, and respiratory rate and 
increase mean arterial blood pressure, cortisol and glucose in goats (Gwendolyn el 
al., 2005). Sakamoto and others (1997) suggested that,  in late pregnant goats, 
Medetomidine induced a decrease in maternal cardiac output, a decrease in 
intrauterine pressure (IUP) arising from the induction of uterine contractions, and 
transplacental Medetomidine can have a suppressive effect on the fetus (transient 
decrease and increase in the fetus heart rate and arterial blood pressure 
respectively). 
1.5.7 Use of Medetomidine in goats  
Medetomidine provides light to heavy sedation according to the dose rate 
administered. The use of this agent alone provides satisfactory sedation for restraint 
or can be used for premedication prior to induction of anaesthesia with other agents 
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(Hall et al., 2001). After Medetomidine was administered in goats, recumbency 
occurred 89 ± 50 seconds after administration (Gwendolyn el al., 2005). 
In Nubian goats, intravenous injection of medetomidine Hcl at dose rate of 
10 µg/kg caused the animals to assume recumbancy position (Nuha, 2004). 
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CHAPTER TWO 
Materials and methods 
2.1. Place of study  
This study was conducted at the premises of the Department of Clinical 
Studies, Faculty of Veterinary Science, University of Nyala, South Darfur, Sudan.  
2.2 Experimental animals 
A total number of sixty four adult female desert goats, their ages ranging 
between 2 – 3 years, and weighing between 17 – 25 kilograms were used in this 
study. Animals were randomly allocated to eight groups of equal size. Before the 
start of the experiments the animals were examined clinically to prove freedom 
from diseases. The animals were kept half grazing at the University of Nyala farm 
with complementary feeding was provided in pens at night. 
2.3 Drugs 
Three pre-anaesthetic medications and two anaesthetics were used and they 
were as follows: 
1. Diazepam (0.5%) (Shanghai pharmaceutical company (SHAPHAR), China) as 
shown in figure (2.1). 
2. Xylazine Hcl (Rompun 2%, alfasan, Holland) Figure (2.1). 
3. Medetomidine Hcl (Domitor 0.1%, Rion pharma, Finland) Figure (2.1). 
4. Ketamine Hcl (5%, USA, TRITTAU, Germany) Figure (2.2). 
5. Thiopentone sodium (THIOSOL, B.P, 500mg, India) Figure (2.2). 
2.4 Injection set 
Disposable syringes 1, 5, and 10 ml, 21 to 24 G (ELASHER, EGYPT), and 
intravenous catheters (21G) were used for intravenous injection of drugs (Figure 
(2.3). 
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A = Xylazine, B = Medetomidine (Domitor), C = Diazepam 
Figure (2.1) Pre-anaesthetic medications used in different protocols 
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A = Thiopental, B = Ketamine Hcl 
Figure (2.2) The intravenous anaesthetic drugs used in the different protocols 
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A = size 1 ml plastic syringe, B = size 1 ml glass syringe, C = size 5 ml plastic 
syringe, D = intravenous catheter 
Figure (2.3) Syringes with different size levels used in performing anaesthetic 
protocols 
A  B  C  D 
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A = Phonendoscope (stethoscope), B = Digital thermometer 
 
Figure (2.4) Monitoring tools used for monitoring physiological parameters 
tested 
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2.5 Monitoring tools 
Phonendoscope (stethoscope) was used for monitoring heart rate, 
Observation of abdominal movements and/or Phonendoscope (stethoscope) were 
used for monitoring respiration. Digital thermometer was used for monitoring rectal 
temperature. Stop watch was used to determine the length of different phases of 
anaesthesia and monitoring reflexes every 10 minutes (Figure, 2.4)  
2.6 Anaesthetic protocols 
Eight different anaesthetic protocols were tested in this investigation as 
follows: 
1. Ketamine Hcl (KT) at dose rate 4 mg/kg (without premedication). 
2. Thiopentone sodium (TH) 2.5% at dose rate 10mg/kg (Without premedication). 
3. Diazepam 0.5 mg/kg + Ketamine at dose rate 4 mg/kg (KT-DI). 
4. Xylazine 0.1 mg/kg + Ketamine Hcl 4 mg/kg (KT-XY). 
5. Medetomidine 10 µg/kg + Ketamine Hcl 4 mg/kg (KT-ME).   
6. Diazepam 0.5 mg/kg + Thiopentone sodium (2.5%) at dose rate 10 mg/kg (TH-
DI). 
7. Xylazine (2%) 0.1 mg/kg + Thiopentone sodium (2.5%) at dose rate 10 mg/kg 
(TH-XY).   
8. Medetomidine 10 µg/kg + Thiopentone sodium (2.5%) at dose rate 10 mg/kg 
(TH-ME).   
2.7 Experimental design 
Each of the above mentioned protocols was tested in eight animals. The 
jugular vein was used for injecting all drugs using intravenous catheter. To start 
each of the premedication containing protocols (group 3 to group 8), animals were 
injected with one of the selected premedications (Diazepam, Xylazine or 
Medetomidine) slowly intravenously, followed after 10 minutes with a rapid 
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intravenous injection of one of the selected anaesthetics (Ketamine Hcl or 
Thiopentone sodium), as follows: 
2.7.1 First experiment 
Animals in this group received rapid intravenous injection of Ketamine Hcl 
(4 mg/kg) without premedication. 
2.7.2 Second experiment 
This group of animals received rapid intravenous injection with Thiopentone 
sodium (2.5%, at dose rate of 10 mg/kg) without premedication. 
2.7.3 Third experiment 
Animals in this group received slow intravenous injection of Diazepam (as a 
premedication) (0.5 mg/kg), followed after ten minutes by rapid intravenous 
injection of Ketamine Hcl (4 mg/kg).  
2.7.4 Fourth experiment 
In this group, animals were injected slowly via intravenous route with 
Xylazine (0.1 mg/kg) as a premedication, anaesthesia was then induced after ten 
minutes by rapid intravenous injection of Ketamine Hcl (4 mg/kg). 
2.7.5 Fifth experiment 
Another group of eight animals was injected slowly through intravenous 
route with Medetomidine (10 µg/kg) as a premedication, followed after ten minutes 
by rapid intravenous injection of Ketamine Hcl (4 mg/kg). 
2.7.6 Sixth experiment 
A group of eight animals received a slow intravenous injection with 
Diazepam (0.5 mg/kg) as premedication, followed after ten minutes by rapid 
intravenous injection of Thiopentone sodium (10mg/kg). 
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2.7.7 Seventh experiment 
A group of eight animals was injected slowly via intravenous route with 
Xylazine (0.1 mg/kg) as a premedication, followed after ten minutes by rapid 
intravenous injection of Thiopentone sodium (10 mg/kg). 
2.7.8 Eighth experiment 
A group of eight animals was injected at slow rate through intravenous route 
with Medetomidine (10 µg/kg) as a premedication, followed after ten minutes by 
rapid intravenous injection of Thiopentone sodium (10 mg/kg). 
Each group of animals was monitored before anaesthesia, during anaesthesia 
and till recovery occurred. 
2.8 Physiological parameters  
Physiological parameters were monitored at 10 minutes intervals using 
standard methods as described by Kelly (1984) as follows: 
2.8.1 Respiratory rate 
Observations of abdominal movements and/or Phonendoscope (stethoscope) 
were used for monitoring respiration. 
2.8.2 Heart rate 
Phonendoscope (stethoscope) was used for monitoring the heart rate through 
the left 3 rd – 5th intercostal spaces.  
2.8.3 Rectal temperature  
Digital thermometer as used for monitoring rectal temperature. The 
thermometer bulb was lubricated with lubricant jell then inserted into the empty 
rectum as described by Kelly (1984). 
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2.9 Phases of anaesthesia 
2.9.1 Induction phase 
It is the state or condition in which the animal start becomes unconscious, 
not responding to painful stimuli with disappearance of selected reflexes (Jani et 
al., 1982)   
2.9.2 Anaesthetic phase 
Was considered as the period during which the animal showed signs of 
unconsciousness, no reflexes and not responding to painful stimuli (Tamisto et al., 
1981).  
2.9.3 Basal narcosis 
Was assessed as the period during which the animal shows signs of 
unconsciousness, but response positively to noxious or painful stimuli (Atkinson, 
Rashman, and Alfredlee, 1987). 
2.9.4 Lateral recumbancy 
Was considered as the duration at which the animal opens its eyes and 
reflexes were regained but it is incapable of adopting sternal position (Thurmon et 
al., 1996).  
2.9.5 Sternal recumbancy 
Was considered as the period during which the animal could adopt sternal 
recumbancy without falling to lateral recumbancy and without adopting standing 
position (Ghurashi, 1999)  
2.9.6 Standing phase 
It is the stage at which the animal can stand but unable to walk ten steps 
(Ghurashi, 1999)  
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2.9.7 Recovery 
The animal was considered to be recovered from anesthesia when it is cable 
of supporting itself in standing position and walk for ten steps without falling down 
(Ghurashi, 1999).  
2.9.8 Total recovery  
Total recovery time was considered as the total time calculated from the time 
of induction of anesthesia until recovery was attained (Nuha, 2004).  
2.10 Reflexes 
2.10.1Tongue reflex 
Was assessed by pulling the tongue outside the mouth, when the animal was 
capable to pull its tongue into the mouth, the reflex was considered positive (Nuha, 
2004). 
2.10.2 Palpepral reflex 
The reflex was assessed by digital touch on the canthus or eyelashes, if 
purposeful motor reflex observed, the reflex was consider positive as reported by 
Batoul, (1990). 
2.10.3 Swallowing reflex 
External digital pressure on the larynx was used to assess Swallowing reflex. 
Positive response was considered when swallowing or laryngeal movements were 
observed (Rawling and Kolata, 1983).  
2.10.4 Pedal reflex 
Pedal reflex was assessed by gentle pressure on the animal fore digit. If the 
animal moves its leg or leg muscle, the reflex was considered positive. 
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2.10.5 Jaw relaxation reflex 
Persistence of open mouth due to induced jaw retraction was considered to 
be a positive jaw relaxation reflex. The reflex was considered regained when the 
animal was reluctant to open its mouth.    
 2.10.6 Anal reflex 
Anal reflex was assessed by inducing tension of anal sphincter with two 
fingers. Positive response was considered when the movement of the anal sphincter 
was observed. 
2.10.7 Cough reflex 
Gentle digital pressure on the first 3rd tracheal cartilage was used to assess 
Cough reflex. Positive response was considered when the cough was induced 
(Blood and Henderson, 1994). 
2.11 Statistical analysis 
For physiological parameters (Respiratory rate, Heart rate and Rectal 
temperature) comparison, T- test was used to compare means, while ANOVA was 
used for compare and contrast between the different anaesthetic phases using SAS 
System computer package.  
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CHAPTER THREE 
Results 
3.1. Effects of different anaesthetic protocols on the respiratory rate, heart 
rate and rectal temperature: 
When Ketamine Hcl was used without premedication as shown in table (1) 
we observed that, there was significant (P≤0.05) increase in the respiratory rate at 
times (0, 10, and 20) minutes and a significant decrease (P≤0.05) in 40 minute 
following induction of anaesthesia, while there is no significant change in heart rate 
or rectal temperature observed during Ketamine Hcl anaesthesia.   
When Ketamine was used with diazepam as shown in Table (2) there was 
non significant (P≥0.05) decrease in the respiratory rate at times (0, 10, 30 and 40) 
minutes and a non significant (P≥0.05) increase at time 20 minute following 
induction of anaesthesia. The heart rate increased non significantly at times (10 and 
20) minutes. Also the rectal temperature expressed non significant change.  
The use of Ketamine with Xylazine as shown in table (3) induced significant 
increase (P≤ 0.05) in the respiratory rate which was observed at time 10 minutes 
and a significant (P≤0.05) decrease was also observed at time 30 minutes following 
induction of anaesthesia, while the heart rate and rectal temperature remained 
without any significant change. 
As shown in table (4), the combination of Ketamine with Medetomidine, 
induced a significant (P≤0.05) increase in the respiratory rate at time (10 and 40) 
minutes following induction of anaesthesia, while the heart rate and rectal 
temperature showed non significant changes. 
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Table (1) Effects of Ketamine Hcl on physiological parameters (respiratory rate, heart rate and rectal temperature) 
during the course of anaesthesia 
Parameters Time (minutes) 
Base line value                        0                    10                       20                        30                      40                        50 
 
Respiratory rate          25.3±1.5                      38±4.0*        31.8±3.6*           33.5±4.3*            33.1±3.6           20.4±3.7*           30.7±3.4 
(breath/min) 
 
Heart rate                     82.8±6.6                   84.4±8.5         91.5±6.8             86.5±5.3               83.4±5.4           80.4±3.9            78.4±3.4 
(beat/min) 
 
Rectal temperature      39.3±0.16                39.3±0.14       39.5±0.15            39.5±0.18             39.7±0.19         39.6±0.19           39.6±0.2 
       (°C) 
Values are mean ± Standard error of mean of eight replicates each 
* P ≤ 0.05 
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Table (2) Effects of protocol KT-DI on physiological parameters (respiratory rate, heart rate and rectal temperature) 
during the course of anaesthesia 
Parameters Time (minutes) 
      Base line value              0                             10                              20                         30                                40                            
 
Respiratory rate          22.6±1.4                 16.8±2.3               15.50±2.2                 27.0±4.8                  22.2±2.55                  22.0±6.0 
(breath/min) 
 
Heart rate                    60.5±3.3                  78.3±7.3                78.3±9.4                 76.3±9.4                    66.7±6.0                 67.0±1.0 
(beat/min) 
 
Rectal temperature      38.0±0.32               38.7±0.34              38.6±0.33                38.6±0.23                  38.4±0.17             37.4±11.22 
       (°C) 
 
Values are mean ± Standard error of mean of eight replicates each 
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Table (3) Effects of protocol KT-XY on physiological parameters (respiratory rate, heart rate and rectal 
temperature) during the course of anaesthesia 
Parameters Time (minutes) 
Base line value                 0                         10                      20                        30                         40                      50 
 
Respiratory rate          28.5±2.7              24.4±5.6           39.6±7.1*           27.8±5.1                26.5±6.1*            27.4±5.3           30.0±6.7        
(breath/min) 
 
Heart rate                  73.3±4.8                69.4±5.2             60.3±3.9             56.5±3.1                60.8±2.8           60.4±3.4             59.5±3.7 
(beat/min) 
 
Rectal temperature    38.5±0.3              38.6±0.4              38.6±0.4             38.6±0.4                38.2±0.4              38.4±0.5           38.6±1.0 
       (°C) 
 
Values are mean ± Standard error of mean of eight replicates each 
*P ≤ 0.05 
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Table (4) Effects of protocol KT-ME on physiological parameters (respiratory rate, heart rate and rectal 
temperature) during the course of anaesthesia 
Parameters Time (min) 
       Base line value               0                  10                        20                    30                       40                           50 
 
Respiratory rate          22.0±1.1              20.0±2.3          29.3±5.5***         18.3±2.1         17.5±2.0            25.3±5.9***           22.3±1.3 
(breath/min) 
 
Heart rate                    90.5±5.1              77.3±3.5           76.0±3.9            70.8±3.5           66.0±3.2                 67.3±3.4              70.5±2.6 
(beat/min) 
 
Rectal temperature       38.6±0.3             38.6±0.5            38.1±0.3           37.9±0.3           37.5±0.4                 37.3±0.4             37.2±0.4 
       (°C) 
Values are mean ± Standard error of mean of eight replicates each 
***P ≤ 0.0001 
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Figure (3.1) Effects of Ketamine Hcl on physiological parameters (respiratory rate, heart rate and rectal 
temperature) during the course of anaesthesia 
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Figure (3.2) Effects of protocol KT-DI on physiological parameters (respiratory rate, heart rate and 
rectal temperature) during the course of anaesthesia  
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Figure (3.3) Effects of protocol KT-XY on physiological parameters (respiratory rate, heart rate and 
rectal temperature) during the course of anaesthesia 
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Figure (3.4) Effects of protocol KT-XY on physiological parameters (respiratory rate, heart rate and 
rectal temperature) during the course of anaesthesia 
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When Thiopentone sodium was used without premedication as elaborated in 
Table (5) we observed that, there was non significant (P≥0.05) decrease in the 
respiratory rate at time (0 and 10) minutes and non significant (P≥0.05) increase at 
time (20, 30, 40, and 50) minutes following induction of anaesthesia. Heart rate 
was significantly (P≤0.05) increased all over the duration of anaesthesia course, 
while rectal temperature was increased significantly (P≤0.05) immediately after 
induction of anaesthesia.  
The protocol Thiopentone sodium with diazepam as shown in table (6), 
induced significant (P≤0.05) decrease in the respiratory rate which was observed 
following induction of anaesthesia at time 10 minutes, then another significant 
(P≤0.05) increase at time 50 minutes following induction of anaesthesia was also 
observed. The heart rate was significantly (P≤0.05) increased at times (10, 20 and 
50) minutes following induction of anaesthesia. Rectal temperature was increased 
significantly (P≤0.05) immediately following induction of anaesthesia and a non 
significant change was observed at times (10, 20, 30 and 40) minutes.  
Injection of Thiopentone sodium with Xylazine as shown in Table (7) 
showed that, a significant (P≤0.05) decrease in the respiratory rate was observed at 
times (10, 30, 40 and 50) minutes post induction of the anaesthesia. Heart rate 
increased significantly (P≤0.05) at times (10, 20 and 30) minutes, while rectal 
temperature showed a non significant change. 
The combination of Thiopentone sodium with Medetomidine as shown in 
table (8) induced a non significant (P≥0.05) decrease in the respiratory rate at times 
(0, 10, 40 and 50) minutes following induction of anaesthesia. Heart rate was 
decreased significantly (P≤0.05) at times (10, 20, 40 and 50) minutes, while rectal 
temperature remained without any significant change until 40 minute. 
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Table (5) Effects of Thiopentone sodium on physiological parameters (respiratory rate, heart rate and rectal 
temperature) during the course of anaesthesia 
 
Parameters Time (min) 
       Base line value           0                        10                     20                          30                      40                     50 
 
Respiratory rate           29.0±2.7            23.0±3.6             28.3±2.4           29.3±2.7                31.0±2.9            33.0±2.6           29.6±3.1 
(breath/min)  
 
Heart rate                      84.0±1.5           100.5±3.9*          95.8±8.1***      108.8±8.1***     94.0±5.8**       95.1±5.3**       97.3±4.5** 
(beat/min) 
 
Rectal temperature        38.8±0.3           39.1±0.1**          39.0±0.2           39.1±0.2              39.1±0.2           39.2±0.2          39.3±0.2 
       (°C) 
 
Values are mean ± Standard error of mean of eight replicates each 
*P ≤ 0.05 
**P ≤ 0.001 
***P ≤ 0.0001 
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Table (6) The effects of protocol TH-DI on physiological parameters (respiratory rate, heart rate and rectal 
temperature) during the course of anaesthesia 
Parameters Time (min) 
        Base line value                 0                 10                        20                   30                         40                       50 
 
Respiratory rate             28.5±2.1                18.3±4.4         15.5±1.5*         20.0±2.6           24.0±3.5              25.8±3.0              35.1±5.3* 
(breath/min) 
 
Heart rate                       72.6±3.0               82.8±4.4         85.8±4.5*          86.5±5.6*          83.9±4.3             84.8±6.5              88.0±7.7* 
(beat/min) 
 
Rectal temperature        38.81±0.1            39.1±0.2*          39.0±0.2          38.9±0.2            38.8±0.1               38.9±0.2             38.8±0.2 
       (°C) 
 
Values are mean ± Standard error of mean of eight replicates each 
*P ≤ 0.05 
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Table (7) The effects of protocol TH-XY on physiological parameters (respiratory rate, heart rate and rectal 
temperature) during the course of anaesthesia 
Parameters Time (min) 
    Base line value                    0                   10                         20                     30                      40                     50 
 
Respiratory rate            27.3±1.1                8.5±0.9           18.0±5.7***         13.3±2.1         17.3±3.9**          21.5±4.2**     18.8±3.5** 
(breath/min)  
 
Heart rate                      87.0±3.8               105.5±8.5          94.3±9.0*          87.3±10.5*       88.8±10*             86.8±7.6          84.8±7.2 
(beat/min) 
 
Rectal temperature        38.8±0.3               38.9±0.3             38.7±0.4            38.4±0.4          38.3±0.4              38.1±0.4           37.9±0.5 
       (°C) 
 
Values are mean ± Standard error of mean of eight replicates each 
*P ≤ 0.05 
**P ≤ 0.001 
***P ≤ 0.0001 
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Table (8) The effects of protocol TH-ME on physiological parameters (respiratory rate, heart rate and rectal 
temperature) during the course of anaesthesia 
Parameters Time (min) 
 
    Base line value              0                          10                      20                      30                      40                        50 
 
Respiratory rate           28.3±0.9            14.5±4.4***        20.3±2.4 *         20.0±1.6            14.5±1.8            16.5±3.1**         19.0±3.0** 
(breath/min) 
  
Heart rate                     84.8±2.2             94.0±4.9              81.8±6.4*          82.0±7.0**        71.3±3.7         74.0±5.4*            73.3±7.3** 
(beat/min) 
 
Rectal temperature       38.8±0.1            39.0±0.1              38.9±0.1            38.7±0.2              38.6±0.2          38.4±0.3             38.4±0.3* 
       (°C) 
 
Values are mean ± Standard error of mean of eight replicates each 
*P ≤ 0.05 
**P ≤ 0.001 
***P ≤ 0.0001 
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Figure (3.5) The effects of Thiopentone sodium on physiological parameters (respiratory rate, heart rate and 
rectal temperature) during the course of anaesthesia 
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Figure (3.6) The effects of protocol TH-DI on physiological parameters (respiratory rate, heart rate and 
rectal temperature) during the course of anaesthesia 
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Figure (3.7) The effects of protocol TH-XY on physiological parameters (respiratory rate, heart rate and 
rectal temperature) during the course of anaesthesia 
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Figure (3.8) The effects of protocol TH-ME on physiological parameters (respiratory rate, heart rate and 
rectal temperature) during the course of anaesthesia
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Following induction of anaesthesia, significant (P≤0.05) decrease was observed at 
time 50 minutes.  
3.2. Duration of different anaesthetic phases following induction of anaesthesia 
with different anaesthetic protocols: 
As shown in table (9), the duration of different anaesthetic phases was found 
to be as follow:  
Generally, Thiopentone sodium containing protocols (TH-DI; TH-XY; TH-
ME) was found to have longer mean periods of anaesthetic phases (25.5±8.9; 
29.4±10.3; 30.3±11.2) minutes respectively, when compared to that observed with 
Ketamine (5.5±2.7 minutes) or Thiopentone sodium (6.6±6.3 minutes) were used 
without premedication. Other protocols were between them KT-XY (18.7±9.2); 
KT-ME (18.2±7.0); KT-DI (17.6±3.2) minutes. 
The protocol TH-ME was found to have longer time of basal narcosis 
(10.7±8.4) minutes, other protocols in descending order were as follows: KT-DI 
(6.4±2.8); KT-XY (6.4±2.8); TH-DI (5.5±4.2); KT-ME (4.3±0.6); TH-XY 
(4.2±1.6); TH (3.5±4.0); and KT (2.0±0.9) minutes. 
The longer mean period of lateral recumbancy phase was reported to be with 
the protocol KT-ME with a mean value of (10.1±3.9) minutes. Other protocols 
descended as follow: TH-XY; TH-DI; TH-ME; KT-XY; TH; KT-DI; and KT with 
mean values of (9.7±4.6; 9.3±6.7; 6.9±5.7; 6.2±3.0; 5.7±9.3; 5.3±2.2; and 1.6±1.0) 
minutes respectively. 
The descended mean values of sternal recumbancy phase in the different 
anaesthetic protocols tested was as follow: (TH-DI; TH-XY; KT-ME; TH-ME; TH; 
KT-DI; KT; and KT-XY) and the mean values were (14.9±6.5; 10.0±9.4; 9.7±8.4; 
8.9±4.9; 8.8±6.2; 7.6±6.8; 6.1±8.2; and 2.3±2.4) minutes respectively.   
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The longer mean value of standing phase was reported to be with the 
protocol TH-DI (11.4±7.6) minutes. Other protocols descended as follow: KT+DI; 
KT-XY; TH; TH-ME; KT; TH-XY; and KT-ME with mean values of (7.1±6.4; 
2.2±4.4; 2.0±2.0; 1.8±2.3; 1.4±0.9; 1.3±1.0; and 1.1±0.9) minutes respectively.  
Table (11), shows that there was significant (P≤0.05) increase in total 
recovery time (TRT) when premedication was used prior to anaesthesia with 
Ketamine or thiopental. Also generally, Thiopentone sodium containing protocols 
have significant (P≤0.05) longer duration of TRT than Ketamine containing 
protocols. 
 3.3. Signs observed following injection of selected premedications 
When diazepam was injected intravenously into animals, ataxia, star gazing, 
salivation, mooning, spontaneous swallowing and sometimes the animal lied into 
sternal or lateral recumbancy with the head and neck on the flank.   
Following intravenous injection of Xylazine in goats, main signs observed 
were aimless wandering, ataxia, salivation, drop of head and tail, rarely star gazing 
and sometimes animal lied into sternal recumbancy.  
The main sings observed following injection of Medetomidine were smooth 
way of adopting sternal recumbancy, salivation and mooning. 
3.4. Signs observed following injection of selected anaesthetics 
Following injection of Ketamine without premedication, animals roughly 
lied down on the ground assuming lateral recumbancy or frog attitude and 
sometimes limb paddling. Mooning, nystagmus, dog sitting position and ataxia are 
sometimes observed during anaesthesia course. 
Thiopentone sodium when injected into animals alone, the animals lied down 
on the ground more quiet and sometimes put their heads and neck on the flank 
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region. It’s not uncommon to see paddling, star gazing, and mooning during the 
course of anaesthesia. 
3.5. Signs observed due to injection of different selected combination 
protocols: 
The main signs observed in goats following injection of selected 
combination of anaesthetics protocols were grunting, snoring, ear and/or head 
twitching, paddling with legs, spontaneous swallowing and sometimes chewing 
movements. Regurgitation was observed with only two anaesthetic protocols (KT-
DI and TH-ME) and one of the animals died probably due to aspiration of 
regurgitated materials, and on post mortem ingesta was found in the trachea and 
lungs. Bloat was common with Thiopentone sodium containing protocols. This 
adverse effect was solved by sloping head down the body so that saliva and 
regurgitated material runs freely from the mouth as suggested by Hall and Clarke 
(2001).  
3.6. Effect of different selected anaesthetic protocols on reflexes: 
Table (10) shows the effects of different selected anaesthetic protocols on 
reflexes. 
Palpepral reflex was found to be depressed only with anaesthetic protocols 
KT-DI, TH-XY, TH-DI, and TH-ME for different periods. Those periods were 
found 5.6±1.5; 15.0±4.1; 10.0±4.0 and 8.1±3.1 minutes, respectively. The protocol 
TH-XY was found to have longer depression mean time. 
KT and TH did not affect tongue reflex. TH-ME (43.8±5.3) minutes seem to 
have longer mean time depression of tongue reflex and KT-DI (19.4±3.3) minutes 
have shorter one.  
Swallowing reflex was not affected with the two protocols KT and TH, but it 
was depressed with other selected protocols for different times between TH- XY 
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(26.9±4.5) minutes (longer mean time of depression) and KT-DI (5.6±2.6) minutes 
(shorter one). 
Pedal reflex was not affected with injection of Thiopentone sodium without 
premedication, but it was affected with other protocols for different times. TH-ME 
(35.6±4.6) minutes seem to have the longer mean depression time of pedal reflex 
and KT (6.9±2.4) minutes have the shortest one.  
Jaw relaxation reflex was found to be negative during KT and KT-DI 
anaesthesia. Other selected anaesthetic protocols were reported to be relaxing jaw 
for different periods of time ranging between 40.0±3.8 minutes for TH-XY 
representing the longest mean of depression time and 8.8±4.7 minutes for TH the 
shortest one. 
Most selected anaesthetic protocols were found not to affect the anal reflex 
except TH-DI for 15.6±5.5 minutes, TH-XY for 28.8±6.4 minutes, and TH-ME for 
33.8±4.9 minutes.  
All selected anaesthetic protocols depressed cough reflex for different 
periods namely for TH-XY for 42.5±4.5 minutes; KT-XY for 41.3±2.2 minutes; 
TH-ME for 36.3±3.7 minutes; KT-ME for 28.8±2.2 minutes; TH-DI for 27.5±5.2 
minutes; KT- DI for 20.6±2.4 minutes; KT for 11.3±4.4 minutes; TH for 7.5±2.5 
minutes. 
3.7. Occurrence of apnoea and regaining of spontaneous respiration due to 
Thiopentone sodium 
Apnoea was observed when Thiopentone sodium containing protocols were 
used. As shown in table (12), the longest duration of apnea was induced with 
protocol TH-DI for 75 ± 0.2 seconds, the shortest one was found to be associated 
with protocol TH-XY for 44 ± 0.03 seconds, and TH-ME for 56 ± 0.1 seconds 
between them.    
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Table (9). Duration of different anaesthetic phases after induction of anaesthesia with different selected protocols 
 
Phases 
Anaesthetic 
 
Narcosis 
 
Lateral 
 
Sternal 
 
Standing 
 
KT 5.5±2.7 2.0±0.9 1.6±1.0 6.1±8.2 1.4±0.9 
KT-DI 17.6±3.2 7.6±2.0 5.3±2.2 7.6±6.8 7.1±6.4 
KT-XY 18.7±9.2 6.4±2.8 6.2±3.0 2.3±2.4 2.2±4.4 
KT-ME 18.2±7.0 4.3±0.6 10.1±3.9 9.7±8.4 1.1±0.9 
TH 6.6±6.3 3.5±4.0 5.7±9.3 8.8±6.2 2.0±2.0 
TH-DI 25.5±8.9 5.5±4.2 9.3±6.7 14.9±6.5 11.4±7.6 
TH-XY 29.4±10.3 4.2±1.6 9.7±4.6 10.0±9.4 1.3±1.0 
TH-ME 30.3±11.2 10.7±8.4 6.9±5.7 8.9±4.9 1.8±2.3 
 
Values are mean (min) ± Standard deviation of mean of eight replicates each 
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Figure (3.9) Comparison of different anaesthetic phases in goats subjected to different anaesthetic protocols
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Table (10). The effect of different anaesthetic protocols on selected reflexes 
 
Protocols Palpepral Tongue Swallowing Pedal Jaw relaxation Anal Cough 
KT NA NA NA 6.9±2.4 NA NA 11.3±4.4
KT- DI 5.6±1.5 19.4±3.3 5.6±2.6 11.9±4.7 NA NA 20.6±2.4
KT-XY NA 24.4±5.2 17.5±3.6 21.3±2.9 8.8±4.7 NA 41.3±2.2
KT-ME NA 32.5±2.5 21.9±4.1 15.0±5.0 13.8±4.9 NA 28.8±2.2
TH NA NA NA NA 6.9±2.5 NA 7.5±2.5 
TH-DI 10.0±4.0 26.3±4.1 12.5±3.1 18.8±2.3 22.5±3.1 15.6±5.5 27.5±5.2
TH-XY 15.0±4.1 41.9±4.6 26.9±4.5 31.9±5.1 40.0±3.8 28.8±6.4 42.5±4.5
TH-ME 8.1±3.1 43.8±5.3 24.4±4.7 35.6±4.6 32.5±5.5 33.8±4.9 36.3±3.7
NA = not affected 
Values are mean (min) ± Standard error of mean of eight replicates each 
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Figure (3.10) comparison between the different reflexes tested following application of the different anaesthetic 
protocols 
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Table (11) Duration of Total recovery time (TRT) following administration of different anaesthetic protocols 
Protocols Mean ± S. E   
Duncan 
Grouping  
KT 15.2±3.5 D 
KT-DI 41.2±4.2 B 
KT-XY 35.3±4.5 B 
KT-ME 41.0±2.5 B 
TH 26.4±4.2 D 
TH-DI 66.2±5.1 A 
TH-XY 54.1±5.3 A 
TH-ME 56.5±4.4 A 
Means with the same letter are not significantly different (P>0.05) 
Values are mean (min) ± Standard error (S. E) of mean of eight replicates each 
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Figure (3.11) Comparison of total recovery time (TRT) duration in the different anaesthetic protocols. 
 
Time / minutes 
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Table (12) The occurrence of apnea and regaining time of spontaneous respiration associated with protocols 
containing thiopental 
 
 
Protocols 
Occurrence of apnoea 
/ Sec 
Regaining of spontaneous 
respiration / Sec 
Duration / 
Sec 
 
TH-DI 
 
16 ± 0.05 91 ± 0.36 75 ± 0.2 
TH-XY 
 
20 ± 0.03 64 ± 0.14 44 ± 0.03 
TH-ME 
 
17 ± 0.03 73 ± 0.20 56 ± 0.1 
 
Values are mean (Seconds) ± Standard error of mean of eight replicates each 
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Figure (3.12) occurrence of apnoea and regaining of spontaneous respiration following administration of 
Thiopentone sodium with the three different premedications 
Time/Sec 
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CHAPTER FOUR 
88 
 
CHAPTER FOUR 
Discussion 
With the continuous need for surgical intervention for the treatment and 
control of disease conditions in animals; development in anaesthetic techniques 
is highly required and indispensible in various animal species. 
 The current investigation was carried out to compare and contrast the 
applicability and safety of application of total intravenous anaesthesia using 
number of selected anaesthetic protocols and to provide base line data 
concerning intravenous anaesthesia in desert goats. Pre-anaesthetic medications 
which are used in this study include two α2-adrenoceptor agonists namely, 
Xylazine and Medetomidine, and a benzodiazepine, Diazepam. Anaesthetic 
induction agents included Thiopentone sodium and Ketamine Hcl. 
Induction agents were used either without premedication or in 
combination with one of the three monitored premedications. Selected 
physiological parameters, reflexes and anaesthetic phases were measured during 
the time course of each anaesthetic protocol. The different anaesthetic protocols 
are compared and contrasted and finally graded on the basis of their merits with 
regard to their safety and reliability as well as the duration and the type of 
recovery. 
The significant increase in respiratory rate following induction of 
anaesthesia with Ketamine Hcl observed in this study was supported with the 
remarks of Hall et al., (2001) who reported that, in clinical practice Ketamine 
anaesthesia usually manifested by an increase in respiratory rate. The non 
significant changes in heart rate and rectal temperature observed during 
Ketamine Hcl anaesthesia in this study is in accordance with the findings of 
Dorota et al., (2007) who reported similar results in rabbits.   
The protocol Ketamine-diazepam resulted in non significant changes in 
respiratory rate, heart rate and rectal temperature, this evidence was in 
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agreement with the findings reported by Ghurashi et al., (2009) in desert goats, 
however Muir and Masonen (1982) reported that, this protocol induced 
significant increase in respiratory rate in calves.  
Monitoring respiratory rate following induction of anaesthesia with the 
protocol Ketamine- Xylazine as seen in table (3), induced significant increase 
(P≤ 0.05) in respiratory rate at 10 minutes and significant (P≤0.05) decrease at 
30 minutes following induction of anaesthesia. Nuha (2004) reported non 
significant increase in respiratory rate when used the same protocol in Nubian 
goat kids. The significant decrease in respiratory rate observed at 30 minutes in 
this study is in the same line with findings of Malik and Singh (2007) in horses. 
The non significant increase in respiratory rate was also observed by Muir et al., 
(1977) following administration of Ketamine-Xylazine in horses, and by 
Waterman (1983); Blaze, Holland, and Grant (1988) and Kumar et al., (1976) in 
domestic goats. According to this study heart rate showed non significant 
decrease during Ketamine-Xylazine anaesthesia, this finding is in agreement 
with the results obtained by Wixson et al., (1987) in rats. Nuha (2004) in Nubian 
goat kids; Muir et al., (1977) in horses; Rings and Muir (1982); and Waterman 
(1981) in calves; Colby and Sandford (1982) in cats, reported an immediate 
bradycardia at 5 minutes post injection and it persisted for the whole period of 
anaesthesia. The non significant bradycardia associated with this anaesthetic 
protocol in this study may be due to the Xylazine depressing effect on the 
sympathetic activity and its enhancing effects on the vagal activity (Antancio et 
al., 1973). The non significant change in rectal temperature associated with 
Ketamine-Xylazine supported with the findings of Nuha (2004) and Singh et al., 
(2007). However, Afshar et al., (2005) reported significant decrease in rectal 
temperature at time 30 to 60 minutes in goats.  
The significant increase in respiratory rate resulted due to administration 
of Ketamine-Medetomidine in this study was supported with the findings of Min 
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su, et al., (2004) in rabbits. Nuha (2004) reported a non significant change in 
respiratory rate in Nubian goat kids following the usage of the same protocol. 
Similar results to those of Nuha (2004) were obtained by Serteyn et al., (1993) 
in beagles. However, Moens and Fargetton (1990) reported that the Ketamine-
Medetomidine combination in dogs induced a significant decrease in respiratory 
rate and heart rate.  While non significant decrease in heart rate and rectal 
temperature resulted were in agreement with study of Patricia and Darryl (2002), 
who reported similar results. Nuha (2004) and Moens and Fargetton (1990) 
reported significant decrease in heart rate and rectal temperature. The drop in 
rectal temperature (although non significant) encountered in this study may be 
probably attributed to the hypothermic effect of Medetomidine previously 
reported in rats by Livingston et al., (1984), Virtanen and MacDonald (1985) or 
to the declination of body temperature caused by Ketamine (Beck, 1971). 
The non significant decrease in respiratory rate associated with injection 
of Thiopentone sodium observed in this study was in agreement with the 
findings of Atkinson et al., (1987), Singh and Kumar, (1988) and Taylor, 
(1990). However Ghurashi (2008) reported significant increase in respiratory 
rate in goat kids due to Thiopentone sodium anaesthesia. This study showed that 
heart rate was significantly increased immediately after induction of anaesthesia 
with Thiopentone sodium without premedication, this finding is in agreement 
with the observations reported by Rawling and Kolata (1983) in goats, Karimi, 
(1987) in horses. Although rectal temperature was increased significantly 
immediately after induction of anaesthesia with Thiopentone sodium, Kumar 
and Sharma, (1986), reported non significant effect of Thiopentone sodium on 
rectal temperature in buffaloes. 
Monitoring the respiratory rate after induction of anaesthesia with 
Thiopentone sodium-Diazepam revealed significant decrease in respiratory rate 
and a significant increase at time 50 minute post injection and that agreed with 
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the findings reported by Ghurashi (1999). Significantly increased heart rate was 
observed in this study. Rectal temperature was increased significantly 
immediately after induction of anaesthesia and non significantly at time (10 – 20 
– 30 – 40) minutes post injection of the anaesthetic.  
With the protocol Thiopentone sodium-Xylazine there was a significant 
decrease in respiratory rate, which started immediately after the injection of the 
protocol and continued for up to 50 minutes post induction of anaesthesia. These 
results are in accordance with the findings of Rodendo-Garcia et al., (1997) in 
dogs and Ghurashi (1999) and Nuha (2004) in goat kids. Prolongation of the 
respiratory depressing effect may be due to the use of Xylazine, which was 
reported to have a depressing effect on respiration in horses (McCashin and 
Gabel, 1975) and in dogs (Vainio and Palmu, 1989). Also there may be some 
sort of combined depressing effects on the respiratory rate brought about by 
Xylazine and Thiopentone sodium (Thurmon et al., 1996). The significant 
increase in heart rate following induction of anaesthesia in this study was in 
agreement with finding reported by Ghurashi, (1999) and Nuha, (2004) using 
Thiopentone sodium-Xylazine in goat kids. Immediate tachycardia was similarly 
reported by using Thiopentone sodium in horses (Karimi, 1987), and in goats 
(Contreras and Aspe, 1992). Nuha (2004) reported that the transient tachycardia 
continued only for 5 minutes probably because of the bradycardiogenic effect of 
Xylazine reported in cattle by Kumar and Sharma (1986). Similar to Ghurashi 
(1999) findings, Thiopentone sodium-Xylazine protocol resulted in non 
significant decrease in rectal temperature. On the other hand Nuha (2004) 
reported significant decrease in rectal temperature starting from 20 minutes post 
induction of anaesthesia until full recovery was attained. These results may be 
attributed to the fact that Thiopentone sodium depresses the basal metabolism 
leading to lowering of body temperature (Hall and Clarke, 1991). Also alpha2-
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adrenoceptor agonists were reported to cause a dose dependent hypothermia in 
rats (Livingston et al., 1984)  
Following injection of Thiopentone sodium with Medetomidine, 
respiration was non significantly decreased at 0 – 10 – 40 – 50 minutes after 
induction of anaesthesia. Heart rate was decreased significantly at 10 – 20 – 40 – 
50 minutes post anaesthetic induction. Rectal temperature remained with non 
significant changes until 40 minutes after induction of anaesthesia, significant 
decrease was observed at time 50 minutes following induction of anaesthesia. 
Injection of Diazepam at a dose rate of 0.5mg/kg in goats resulted in 
ataxia, salivation and lateral recumbancy, these findings are in accordance with 
the observations of Ghurashi et al., (2009) in desert goats. Ataxia was also 
reported by Hall et al., (2001).  In this investigation, stargazing, mooning and 
spontaneous swallowing were also noticed.  
In this study, intravenous injection of Xylazine in goats, the main signs 
observed were aimless wandering, ataxia which is also reported to occur in 
horses (Hall et al., 2001), salivation, lowered head and tail, rarely star gazing 
and sometimes animal lied into sternal recumbancy.  
The main observations following injection of Medetomidine were smooth 
quiet adoption of sternal recumbancy, salivation and mooning. 
In this study regurgitation was observed in association with two protocols, 
Ketamine - Diazepam and Thiopentone sodium - Medetomidine. Similar 
observation was reported by Hall et al., (2001). However, Nuha, (2004) did not 
report such observation when used the same protocols in Nubian goat kids 
during her experimental work. Although regurgitation of ruminal contents was 
generally accepted to represent a serious hazard in ruminants during general 
anaesthesia (Hall and Clarke, 1983), it was found that it did not take place in 
almost all experimental animals as reported by Ghurashi, (1999) and Nuha, 
(2004) in goat kids. That lack of regurgitation could probably attributed to the 
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fact that goat kids rather than adult goats were used in Ghurashi and Nuha 
studies. Also Hall and Clarke, (2001) attributed the occurrence of regurgitation 
in adult goats to animal positioning particularly lateral recumbancy position.  
Also tympany was observed after induction of anaesthesia with different 
anaesthetic protocols tested, that is in agreement with findings reported by Nuha 
(2004) who observed slight harmless ruminal tympany following induction of 
anaesthesia with intravenous anaesthestic agents in Nubian goat kids. This 
tympany might be due to the absence of eructation together with occurrence of 
salivation (Blood et al., 1994). 
Generally, Thiopentone sodium containing protocols (TH-DI; TH-XY; 
TH-ME) were found to have longer mean periods of anaesthetic phase 
(25.5±8.9; 29.4±10.3 and 30.3±11.2) minutes respectively, compared to that 
observed with Ketamine (5.5±2.7 minutes) or Thiopentone sodium (6.6±6.3 
minutes) when used without premedication. Other protocols durations were 
between the two categories with KT-XY; KT-ME and KT-DI having durations 
of 18.7±9.2; 18.2±7.0 and 17.63.2 minutes, respectively. 
Induction of anaesthesia with Thiopentone sodium-Xylazine resulted in 
anaesthetic phase with significantly longer duration than that obtained when 
using Ketamine-Xylazine (Nuha, 2004). This result is supported by the findings 
of Kumar et al., (1983) and Kumar and Sharma (1986) who studied the effect of 
premedication with Xylazine on Thiopentone sodium anaesthesia in buffaloes. 
Similarly these results in this investigation are in agreement with the findings of 
Ghurashi (1999), who reported a significant prolongation of anaesthesia phase 
when anaesthesia was induced in goat kids with Thiopentone sodium- Xylazine. 
  The protocol TH-ME was found to have longer duration time of basal 
narcosis (10.7±8.4) minutes. Other protocols descended as follow: KT-DI; KT-
XY; TH-DI; KT-ME; TH-XY; TH and KT, with duration time of (6.4±2.8); 
(6.4±2.8); (5.5±4.2); (4.3±0.6); (4.2±1.6); (3.5±4.0) and (2.0±0.9) minutes, 
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respectively.  Elsewhere the anaesthetic protocol Thiopentone sodium - 
Xylazine resulted in a significant prolongation of the narcosis phase when 
compared with the other anaesthetic protocols (Nuha, 2004). The prolongation 
of the narcosis phase may be due to the profound sedative effect of Xylazine, 
which was also reported in goats by Kenaway and Kassen (1994). 
The longer mean period of lateral recumbancy phase was noticed with the 
protocol KT-ME with a mean value of (10.1±3.9) minutes. Other protocols 
descended as follows: TH-XY; TH-DI; TH-ME; KT-XY; TH; KT-DI; and KT 
with mean values of (9.7±4.6; 9.3±6.7; 6.9±5.7; 6.2±3.0; 5.7±9.3; 5.3±2.2; and 
1.6±1.0) minutes respectively. Significant prolongation of the lateral 
recumbancy phase was observed by Nuha (2004), following induction of 
anaesthesia with Ketamine-Xylazine when compared with the other anaesthetic 
protocols. The significant prolongation of this phase could be mainly attributed 
to the administration of Xylazine which was reported to cause a prolonged 
lateral recumbancy and profound sedation in man (Vickers et al., 1984) and in 
horses (Marroum et al., 1994). 
The descended mean values of sternal recumbancy phase with the 
different protocols tested (TH-DI; TH-XY; KT-ME; TH-ME; TH; KT-DI; KT; 
and KT-XY) was found to be  14.9±6.5; 10.0±9.4; 9.7±8.4; 8.9±4.9; 8.8±6.2; 
7.6±6.8; 6.1±8.2; and 2.3±2.4 minutes, respectively.   
The longer mean value of standing phase was recorded to be with the 
protocol TH-DI (11.4±7.6) minutes. Other protocols descending as follows: KT-
DI; KT-XY; TH; TH-ME; KT; TH-XY; and KT-ME with a mean value of 
(7.1±6.4; 2.2±4.4; 2.0±2.0; 1.8±2.3; 1.4±0.9; 1.3±1.0; and 1.1±0.9) minutes 
respectively. 
The standing time was found to be significantly prolonged following 
induction of anaesthesia with Xylazine-Ketamine in goat kids not undergoing 
laparotomy when compared with the other tested anaesthetic protocols in 
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animals undergoing laparotomy (Nuha, 2004). This prolongation may be due to 
Xylazine injection which was similarly reported to cause difficulty in 
maintaining standing position (Vickers et al., 1984).  
Table (11), shows that there was significant (P≤0.05) increase in total 
recovery time (TRT) when premedications were used prior to the anaesthetic 
Ketamine or Thiopentone sodium. Also Thiopentone sodium containing 
protocols have a significant (P≤0.05) longer duration of TRT than Ketamine 
containing protocols. Induction of anaesthesia with Xylazine - Thiopentone 
resulted in a significantly longer duration of total recovery time compared with 
the other tested anaesthetic protocols (Nuha, 2004). This prolongation might 
probably be attributed to the presence of an additive effect in the combination 
used as suggested by Hutch (1976). 
Total recovery time is now considered to be among the most important 
factors governing the selection of anaesthetic protocols for the various surgical 
operations. A lot of surgeons prefer the use of anaesthetic protocols that can 
ensure adequate duration of anaesthesia for surgery and as same as time 
guarantee a fast, smooth, and uneventful recovery from anaesthesia.  
This study suggested that palpepral reflex remained not affected by all 
tested protocols, a finding which in accordance with the suggestions of Thurmon 
and his colleges (1996), who reported that, the eyes remained open and the 
pupils dilated in animals anaesthetized with Ketamine. Palpepral reflex was not 
affected with the protocols KT-XY and KT-ME. 
Palpepral reflex was affected only with selected anaesthetic protocols KT-
DI, TH-XY, TH-DI, and TH-ME. The protocol TH-XY was found to have 
longer depression mean time with a value of 15 minutes. 
KT and TH did not affect tongue reflex, TH-ME seems to have longer 
mean time of depression of tongue reflex and KT-DI have the shorter depressing 
time.  
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Swallowing reflex was not affected with the protocols KT and TH, but it 
was depressed with other selected protocols for different time intervals ranging 
between TH-ME (longer mean time of depression) and KT-DI (the shorter one). 
Pedal reflex was not affected with injection of thiopental without 
premedication, but it was affected with other protocols for different duration 
times. TH-ME seems to be has longer mean time depression of pedal reflex and 
KT has the shorter one.  
The regaining time of the pedal reflex, palpeberal reflex, tongue reflex, 
jaw reflex, cough reflex and swallowing reflex were monitored during the five 
experiments conducted in this investigation where general anaesthesia was used. 
The mean regaining time of each reflex was compared with the regaining time 
of the same reflex following induction of anaesthesia with the different tested 
anaesthetic protocols. The comparison revealed that, the mean regaining time 
when using Thiopentone sodium as an induction agent in Xylazine premedicated 
animals was significantly longer, probably due the prolongation of the 
anaesthesia phase following induction of anaesthesia with Xylazine -
Thiopentone sodium. 
All reflexes showed non significant differences in their regaining time 
throughout the course of anaesthesia, which was induced using Ketamine Hcl 
(Nuha, 2004). This observation may be attributed to the insufficient suppression 
of reflexes that was considered to be one of the undesirable effects of Ketamine 
(Norwouzian et. al., 1981). 
Palpebral reflex was not affected by anaesthetic protocols xylazine-
ketamine and Medetomidine -Ketamine. The reflex persisted throughout the 
course of anaesthesia. These results support the findings of Thurmon and his 
colleges (1996) who reported that, the eyes usually remain open with the pupils 
dilated in animals anaesthetized with Ketamine. 
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Jaw relaxation reflex was found to be negative during KT and KT-DI 
anaesthesia, while other selected anaesthetic protocols did affect relaxation of 
jaws for different time intervals ranging between those for TH-XY (longer mean 
time of depression) and TH (shortest one). 
Most selected anaesthetic protocols did not affect the anal reflex except 
TH-DI, TH-Y and TH-ME for durations of 15.63, 28.75 and 33.75 minutes, 
respectively. 
All selected anaesthetic protocols used in this investigation were reported 
to depress cough reflex for different periods.  
Apnoea is a common finding observed during Thiopentone sodium 
anaesthesia, its duration with protocol TH-DI was found to be (75 ± 0.2) 
seconds, TH-ME (56 ± 0.1) seconds, and TH-XY (44 ± 0.03) seconds.  
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CONCLUSIONS AND RECOMMENDATIONS 
5.1 Conclusions 
This study was concentrated on the effects of the two anaesthetic 
protocols Ketamine Hcl and Thiopentone sodium with or without premedication 
(Diazepam, Xylazine and Medetomidine) in desert goats to provide baseline 
data pertaining to different anaesthetic phases tested and to compare it within the 
different protocols examined. This study can be concluded as follows: 
1. Each of the protocols tested can be used safely in desert goats except 
potential hazard of bloat and regurgitation which can be solved by sloping 
head down the body so that saliva and regurgitated material runs freely 
from the mouth. 
2. Usage of premedication prior to Thiopentone sodium and Ketamine Hcl 
lead to smooth induction of anaesthesia compared to non premedicated 
animals. Physiological parameters (respiratory rate, heart rate and rectal 
temperature) were affected to different limits. 
3. Usage of premedication prior to Thiopentone sodium and Ketamine Hcl 
caused prolongation in total recovery time. 
4. Regurgitation was observed with two protocols (KT-DI and TH-ME). 
Bloat was common with Thiopentone sodium containing protocols.  
5. 5.2 Recommendations 
Each of the eight tested protocols at the prescribed dose rates is safe for 
use in desert goats, with variable effects on physiological and anaesthetic 
parameters. As a future prospect, more investigation is required to be 
carried out with other anaesthetic protocols using more sophisticated 
monitoring devices.  
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 ﺍﻟﻤﺴﺘﺨﻠﺹ
ﺍﻟﺘـﻲ  ﻭﺭﻴﺩﻴﺔ ﻭﻟﻤﺨﺩﺭﺍﺕ ﺍﻟﺒﻌﺽ ﺒﺭﻭﺘﻭﻜﻭﻻﺕ ﺍﺍﻟﻀﻭﺀ ﻋﻠﻲ ، ﻟﻘﺩ ﺘﻘﺭﺭ ﺘﺴﻠﻴﻁ ﺩﺭﺍﺴﺔﻓﻲ ﻫﺫﻩ ﺍﻟ
ﺘـﻭﻓﻴﺭ  ﻫﻭﺍﻟﺩﺭﺍﺴﺔ  ﻥ ﻫﺫﻩﺍﻟﻬﺩﻑ ﺍﻟﺭﺌﻴﺱ ﻤ. ﻓﻲ ﺍﻟﺴﻭﺩﺍﻥﺇﻨﺎﺙ ﺍﻟﻤﺎﻋﺯ ﺍﻟﺼﺤﺭﺍﻭﻱ  ﻴﻤﻜﻥ ﺇﺴﺘﺨﺩﺍﻤﻬﺎ ﻓﻲ
ﺃﺴﺎﺴﻴﺔ ﺘﺘﻌﻠﻕ ﺒﻘﻴﺎﺱ ﺍﻻﻁﻭﺍﺭ ﺍﻟﺘﺨﺩﻴﺭﻴﺔ ﺍﻟﻤﺨﺘﻠﻔﺔ ﻭﻤﻘﺎﺭﻨﺘﻬﺎ ﺒﺒﻌﻀﻬﺎ ﺒﺎﻟﻌﺽ ﻓـﻲ ﻤﺨﺘﻠـﻑ ﻗﺎﻋﺩﺓ ﺒﻴﺎﻨﺎﺕ 
  .ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ ﺍﻟﺘﻲ ﺘﻡ ﺍﺨﺘﺒﺎﺭﻫﺎ ﻓﻲ ﻫﺫﻩ ﺍﻟﺤﻴﻭﺍﻨﺎﺕ
ﻭ ﺍﻟﻤﺎﻋﺯ ﺍﻟﺼﺤﺭﺍﻭﻱ ﺍﻟﺨﺎﻟﻴﻪ ﻤﻥ ﺍﻻﻤـﺭﺍﺽ  ﺇﻨﺎﺙﻤﻥ  46 ﺒﺎﺴﺘﺨﺩﺍﻡ ﻋﺩﺩ  ﺍﻟﺘﺠﺭﺒﺔﺃﺠﺭﻴﺕ ﻫﺫﻩ 
ﺘﻡ ﺍﺴـﺘﺨﺩﺍﻡ ﻜـل ﻤـﻥ ﻋﻘـﺎﺭ ﺍﻟﻜﻴﺘـﺎﻤﻴﻥ . ﻤﺘﺴﺎﻭﻴﺔ ﺍﻟﻌﺩﺩﻤﺠﻤﻭﻋﺎﺕ  8ﻋﺸﻭﺍﺌﻴﺎﹰ ﺇﻟﻲ  ﺎﺍﻟﺘﻲ ﺘﻡ ﺘﻘﺴﻴﻤﻬ
ﺒﺘﺭﻜﻴـﺯ  (HT) ﺼـﻭﺩﻴﻭﻡ  ﻭﻥﻜﺞ ﻤﻥ ﻭﺯﻥ ﺍﻟﺠﺴﻡ ﻭ ﻋﻘﺎﺭ ﺜﻴﻭﺒﻨﺘ/ﻤﺞ 4ﺒﺠﺭﻋﺔ  (TK) ﻫﻴﺩﺭﻭﻜﻠﻭﺭﻴﺩ
ﻜﺠﻡ ﻤﻥ ﻭﺯﻥ ﺍﻟﺠﺴﻡ ﺘﻡ ﺍﺴﺘﺨﺩﺍﻤﻬﻤﺎ ﺤﻘﻨﺎﹰ ﺒﺎﻟﻭﺭﻴﺩ ﻹﺤﺩﺍﺙ ﺍﻟﺘﺨﺩﻴﺭ، ﻜﻤـﺎ ﺘـﻡ /ﻤﺞ 01ﻭﺒﺠﺭﻋﺔ % 5.2
 (YX) ، ﺍﻟﺯﻴﻼﺯﻴﻥ ﻡﻜﺠ/ ﻤﺞ  5.0ﺒﺠﺭﻋﺔ   (ID) ﻜﻌﻼﺝ ﺘﻤﻬﻴﺩﻱ ﻫﻲ ﺍﻟﺩﻴﺎﺯﺒﺎﻡ ﺍﺴﺘﺨﺩﺍﻡ ﺜﻼﺙ ﻋﻘﺎﻗﻴﺭ
ﺍﺴـﺘﺨﺩﻤﺕ . ﻤـﻥ ﻭﺯﻥ ﺍﻟﺠﺴـﻡ  ﻡﻜﺠ/ ﻤﻜﺞ  01ﺒﺠﺭﻋﺔ  (EM) ﻭ ﺍﻟﻤﻴﺩﻴﺘﻭﻤﻴﺩﻴﻥ ﻡﻜﺠ/ﻤﺞ 1.0ﺒﺠﺭﻋﺔ 
ﻜـل ﻤﺠﻤﻭﻋـﺔ ﻤـﻥ  .ﺩﻗﺎﺌﻕ ﻤﻥ ﺤﻘﻥ ﺍﻟﻌﻘـﺎﺭ ﺍﻟﻤﺨـﺩﺭ  01ﻋﻘﺎﻗﻴﺭ ﺍﻟﻌﻼﺝ ﺍﻟﺘﻤﻬﻴﺩﻱ ﺤﻘﻨﺎﹰ ﺒﺎﻟﻭﺭﻴﺩ ﻗﺒل 
ﻤﻊ ﺃﻭ ﺒـﺩﻭﻥ ﺍﻟﻌـﻼﺝ ( HT)ﺃﻭ  (TK)ﻭﺭﻩ ﺁﻨﻔﺎﹰ ﺘﻡ ﻋﻼﺠﻬﺎ ﺇﻤﺎ ﺒﺈﺴﺘﺨﺩﺍﻡ ﻤﺠﻤﻭﻋﺎﺕ ﺍﻟﺤﻴﻭﺍﻨﺎﺕ ﺍﻟﻤﺯﻜ
،  HT،  EM-TK،  YX-TK،  ID-TK،  TKﻋﻠﻴﻪ ﺍﺼﺒﺤﺕ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ ﻫﻲ     . ﺍﻟﺘﻤﻬﻴﺩﻱ
  . EM-HTﻭ  YX-HT،  ID-HT
ﻗﺒل ﺇﺤﺩﺍﺙ ﺍﻟﺘﺨﺩﻴﺭ، ﻭ ﺒﻌﺩ  ﻤﻌﺩل ﺍﻟﺘﻨﻔﺱ، ﻤﻌﺩل ﻀﺭﺒﺎﺕ ﺍﻟﻘﻠﺏ ﻭ ﺩﺭﺠﺔ ﺤﺭﺍﺭﺓ ﺍﻟﺠﺴﻡﺘﻡ ﻗﻴﺎﺱ 
ﻜـل  ﺕﺭ ﺍﻟﻤﺨﺩﺭﺓ ﻤﺒﺎﺸﺭﺓ ﺜﻡ ﺘﻤﺕ ﻤﺭﺍﻗﺒﺔ ﺍﻟﺤﻴﻭﺍﻨﺎﺕ ﺃﺜﻨﺎﺀ ﺃﻁﻭﺍﺭ ﺍﻟﺘﺨﺩﻴﺭ ﻭ ﺍﺨﺫ ﻫﺫﻩ ﺍﻟﻘﺭﺍﺀﺍﺤﻘﻥ ﺍﻟﻌﻘﺎﻗﻴ
ﻜﺫﻟﻙ ﺘﻤﺕ ﻤﺭﺍﻗﺒﺔ ﺍﻟﻤﻨﻌﻜﺴﺎﺕ ﺍﻻﺴﺎﺴﻴﻪ . ﺩﻗﺎﺌﻕ ﺤﺘﻰ ﺍﻹﻓﺎﻗﺔ، ﺒﺎﺴﺘﺨﺩﺍﻡ ﻁﺭﻕ ﺴﺭﻴﺭﻴﺔ ﻗﻴﺎﺴﻴﺔ ﻤﻌﺘﻤﺩﺓ 01
  .ﺨﻼل ﻓﺘﺭﺓ ﺍﻟﺘﺨﺩﻴﺭ
ﺃﺤﺩﺙ ﺯﻴﺎﺩﺓ ﻤﻌﻨﻭﻴﺔ ﻓﻲ ﻤﻌﺩل ﺍﻟﺘﻨﻔﺱ،  EM-TK ﻭ  YX-TK،  TKﺍﺴﺘﺨﺩﺍﻡ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ 
ﻗـﺩ . ﺇﻟﻰ ﺍﻨﺨﻔﺎﺽ ﻤﻌﻨﻭﻱ ﻓﻲ ﻤﻌﺩل ﺍﻟﺘﻨﻔﺱ YX-HT ﻭ  ID-HTﺒﻴﻨﻤﺎ ﺃﺩﻯ ﺍﺴﺘﺨﺩﺍﻡ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻟﻴﻥ 
، ﺒﻴﻨﻤﺎ YX-HT ﻭ   ID-HT   ،HTﺇﺯﺩﺍﺩ ﻤﻌﺩل ﻀﺭﺒﺎﺕ ﺍﻟﻘﻠﺏ ﻤﻌﻨﻭﻴﺎﹰ ﻋﻨﺩ ﺇﺴﺘﺨﺩﺍﻡ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ 
ﺤـﺭﺍﺭﺓ ﻤﻌﻨﻭﻴـﺎﹰ ﻋﻨـﺩ ﺇﺴـﺘﺨﺩﺍﻡ ﺇﺭﺘﻔﻌﺕ ﺩﺭﺠﺔ ﺍﻟ. EM-HTﺍﻨﺨﻔﺽ ﻤﻌﻨﻭﻴﺎﹰ ﻋﻨﺩ ﺤﻘﻥ ﺍﻟﺒﺭﻭﺘﻭﻜﻭل 
، ﻏﻴﺭ ﺃﻨﻪ ﻟﻡ ﺘﻬـﺒﻁ ﺩﺭﺠـﺔ ﺍﻟﺤـﺭﺍﺭﺓ ﻤﻌﻨﻭﻴـﺎﹰ ﺒﺈﺴـﺘﺨﺩﺍﻡ ﺃﻱ ﻤـﻥ  ID-HTﻭ  HTﺍﻟﺒﺭﻭﺘﻭﻜﻭﻟﻴﻥ 
  .ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ ﺍﻟﺘﻲ ﺘﻤﺕ ﺩﺭﺍﺴﺘﻬﺎ
ﺘﺤﺩﺙ ﺃﻁﻭل ﻓﺘـﺭﺓ ﻟﻁـﻭﺭ ﺍﻟﺘﺨـﺩﻴﺭ،   EM-HTﻭ  YX-HT،  ID-HTﻭﺠﺩ ﺃﻥ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ 
ﻭﺘﻭﻜـﻭﻻﺕ ﺍﻟﻤﺤﺘﻭﻴـﺔ ﻋﻠـﻰ ﺍﻟﻜﻴﺘـﺎﻤﻴﻥ ﻤﻘﺎﺭﻨﺔ ﻤﻊ ﺜﻴﻭﺒﻨﺘﻭﻥ ﺼﻭﺩﻴﻭﻡ ﺒﺩﻭﻥ ﻋـﻼﺝ ﺘﻤﻬﻴـﺩﻱ ﻭ ﺍﻟﺒﺭ 
 TK، ﺒﻴﻨﻤﺎ ﺃﺤﺩﺙ ﺍﻟﺒﺭﻭﺘﻭﻜﻭل  EM-HTﺃﻁﻭل ﻓﺘﺭﺓ ﺘﻬﻭﻴﻡ ﺃﺴﺎﺴﻲ ﺘﻡ ﺇﺤﺩﺍﺜﻬﺎ ﺒﻭﺍﺴﻁﺔ . ﻫﻴﺩﺭﻭﻜﻠﻭﺭﻴﺩ
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ﺃﻁﻭل ﻓﺘﺭﺓ ﺇﺴﺘﻠﻘﺎﺀ ﺠﺎﻨﺒﻲ، ﺒﻴﻨﻤﺎ ﺍﻗﺼﺭ ﻓﺘـﺭﺓ  EM-TKﺃﻅﻬﺭ ﺍﻟﺒﺭﻭﺘﻭﻜﻭل .  ﺃﻗﺼﺭ ﻓﺘﺭﺓ ﻟﻬﺫﺍ ﺍﻟﻁﻭﺭ
ﺒـﺄﻁﻭل ﻓﺘـﺭﺓ  ID-HTﺯ ﺍﻟﺒﺭﻭﺘﻭﻜﻭل ﺘﻤﻴ. ID-TKﺘﻤﺕ ﻤﻼﺤﻅﺘﻬﺎ ﻟﻬﺫﺍ ﺍﻟﻁﻭﺭ ﻜﺎﻨﺕ ﻋﻨﺩ ﺍﺴﺘﺨﺩﺍﻡ  
ﺃﺤـﺩﺙ ﺍﻟﺒﺭﻭﺘﻭﻜـﻭل . ﺃﻅﻬﺭ ﺍﻗﺼﺭ ﻓﺘﺭﺓ ﻓﻲ ﻫﺫﺍ ﺍﻟﻁﻭﺭ YX-TKﺇﺴﺘﻠﻘﺎﺀ ﻗﺼﻲ، ﺒﻴﺩ ﺃﻥ ﺍﻟﺒﺭﻭﺘﻭﻜﻭل 
ﺃﻅﻬﺭ ﺍﻗﺼﺭ ﻓﺘﺭﺓ ﻭﻗـﻭﻑ ﻤـﻥ ﺒـﻴﻥ  TK-EMﺃﻁﻭل ﻓﺘﺭﺓ ﻭﻗﻭﻑ، ﻏﻴﺭ ﺃﻥ ﺍﻟﺒﺭﻭﺘﻭﻜﻭل  ID-HT
ﺭ ﻭ ﺯﻤـﻥ ﺭﺠـﻭﻉ ﻟﻡ ﺘﻼﺤﻅ ﺃﻱ ﻋﻼﻗﺔ ﻭﺍﻀﺤﺔ ﺒﻴﻥ ﺃﻁﻭﺍﺭ ﺍﻟﺘﺨـﺩﻴ . ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ ﺍﻟﺘﻲ ﺘﻡ ﺇﺨﺘﺒﺎﺭﻫﺎ
  .ﺍﻟﻤﻨﻌﻜﺴﺎﺕ ﺍﻟﺘﻲ ﺘﻤﺕ ﻤﺭﺍﻗﺒﺘﻬﺎ
ﻋﻨﺩ ﺇﺴـﺘﺨﺩﺍﻡ ﺍﻟﻌـﻼﺝ  )TRT( ﺃﻅﻬﺭﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺃﻥ ﻫﻨﺎﻟﻙ ﺯﻴﺎﺩﺓ ﻤﻌﻨﻭﻴﺔ ﻓﻲ ﺍﻟﺯﻤﻥ ﺍﻟﻜﻠﻲ ﻟﻺﻓﺎﻗﺔ 
ﺍﻟﺘﻤﻬﻴﺩﻱ ﻗﺒل ﺍﻟﻜﻴﺘﺎﻤﻴﻥ ﻫﻴﺩﺭﻭﻜﻠﻭﺭﻴﺩ ﺃﻭ ﺜﻴﻭﺒﻨﺘﻭﻥ ﺼﻭﺩﻴﻭﻡ، ﻜﺫﻟﻙ ﻋﻤﻭﻤﺎﹰ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ ﺍﻟﻤﺤﺘﻭﻴﺔ ﻋﻠﻰ 
ﺎﺩﺓ ﻤﻌﻨﻭﻴﺔ ﻓﻲ ﺍﻟﺯﻤﻥ ﺍﻟﻜﻠﻲ ﻟﻺﻓﺎﻗﺔ ﻤﻘﺎﺭﻨﺔ ﻤـﻊ ﺍﻟﺒﺭﻭﺘﻭﻜـﻭﻻﺕ ﺜﻴﻭﺒﻨﺘﻭﻥ ﺼﻭﺩﻴﻭﻡ ﻭﺠﺩ ﺃﻨﻬﺎ ﺘﺤﺩﺙ ﺯﻴ
  .  ﺍﻟﻤﺤﺘﻭﻴﺔ ﻋﻠﻰ ﺍﻟﻜﻴﺘﺎﻤﻴﻥ ﻫﻴﺩﺭﻭﻜﻠﻭﺭﻴﺩ
ﻋﻨﺩ ﺤﻘﻥ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ ﺍﻟﻤﺤﺘﻭﻴﺔ ﻋﻠﻰ ﺜﻴﻭﺒﻨﺘﻭﻥ ﺼﻭﺩﻴﻭﻡ، ﺤﻴﺙ ﻭﺠﺩ ( aeonpA)ﻟﻭﺤﻅ ﺘﻭﻗﻑ ﺍﻟﺘﻨﻔﺱ 
 ﻭ ﺃﻗﺼـﺭﻫﺎ ﺒﺈﺴـﺘﺨﺩﺍﻡ  ID-HTﺃﻥ ﺃﻁﻭل ﻓﺘﺭﺓ ﺘﻭﻗﻑ ﻟﻠﺘﻨﻔﺱ ﻜﺎﻨـﺕ ﻋﻨـﺩ ﺇﺴـﺘﺨﺩﺍﻡ ﺍﻟﺒﺭﻭﺘﻭﻜـﻭل 
  .YX-HTﺍﻟﺒﺭﻭﺘﻭﻜﻭل 
ﺨﻠﺼﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺇﻟﻰ ﺃﻥ ﻜل ﻤﻥ ﺍﻟﺒﺭﻭﺘﻭﻜﻭﻻﺕ ﺍﻟﺜﻤﺎﻨﻴﺔ ﺍﻟﺘﻲ ﺘﻡ ﺇﺨﺘﺒﺎﺭﻫﺎ ﺤﺴﺏ ﺍﻟﺠﺭﻉ ﺍﻟﻤﻭﻀـﺤﺔ 
ﻴﻤﻜﻥ ﺇﺴﺘﺨﺩﺍﻤﻬﺎ ﺒﺄﻤﺎﻥ ﻓﻲ ﺇﻨﺎﺙ ﺍﻟﻤﺎﻋﺯ ﺍﻟﺼﺤﺭﺍﻭﻱ، ﻤﻊ ﻤﻼﺤﻅﺔ ﺤﺩﻭﺙ ﺁﺜﺎﺭ ﻤﺘﻔﺎﻭﺘﺔ ﻋﻠﻰ ﺍﻟﻤـﺩﻟﻭﻻﺕ 
 .ﺍﻟﻔﺴﻴﻭﻟﻭﺠﻴﺔ ﻭ ﺍﻟﺘﺨﺩﻴﺭﻴﺔ
